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ABSTRACT 
 
Proteins involved in the blood coagulation cascade are of vital biomedical importance, 
and most essential blood-clotting reactions occur preferentially on phospholipid membranes. 
Understanding the interactions between the proteins and membranes involved in blood clotting is 
crucial to the continued development of successful treatments for blood coagulation disorders 
such as hemophilia, von Willebrand disease, and thrombosis. In normal hemostasis, the blood-
clotting cascade is initiated when factor VIIa (fVIIa, other clotting factors are named similarly) 
binds to human tissue factor (TF), a 29 kDa integral membrane protein. The TF/fVIIa complex in 
turn activates fX and fIX, eventually concluding with clot formation. Several X-ray crystal 
structures of the extracellular domain of TF (sTF) exist; however, some of these structures are 
lacking electron density in functionally important dynamic loops that can be accessed using 
nuclear magnetic resonance (NMR) spectroscopy. 
Here, the nanocrystalline and membrane-bound forms of TF are investigated with solid-
state NMR and compared to the previously published solution NMR sTF assignments. We have 
prepared several samples of the sTF with uniform (U)-13C, 15N labeling and a variety of 13C 
sparse labeling schemes, precipitated with polyethylene glycol and ammonium sulfate. A suite of 
interresidue and intraresidue multidimensional solid-state NMR experiments have been acquired 
in order to complete the chemical shift assignments of microcrystalline sTF and compare the 
effects of different precipitation agents on chemical shifts, focusing on the loop residues missing 
in the X-ray crystal structures. The dynamics of TF has also been investigated using solution 
NMR relaxation experiments, solid-state T-MREV experiments to extract order parameters, and 
molecular dynamics simulations.  
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(U)-13C, 15N mTF samples, a construct that includes the transmembrane helix, have been 
incorporated into both phospholipid Nanodiscs and POPC/DPPC liposomes. The impact of 
different lipid preparations on the structure of TF as well as mTF functional assay data are 
presented. Our preliminary results indicate that TF retains its primarily beta-sheet secondary 
structure upon membrane binding; however, perturbations are observed in several flexible loops 
near the membrane surface that have been shown to be necessary for enzymatic activity. These 
studies provide a deeper understanding of the structure and mechanism of the vital blood 
coagulation protein TF in atomistic detail.  
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CHAPTER 1  
Introduction 
 
1.1 Preface 
Understanding the structures of protein complexes at atomic-scale resolution provides 
invaluable insight into protein function and mechanism. With this knowledge, selective 
therapeutics could be developed that specifically target regions of interest in the protein. In the 
context of blood coagulation, detailed structural information could enable more effective 
regulation of clotting, especially in individuals with clotting disorders. Blood clotting gone awry 
can cause rapid, life-threatening complications, as in the case of deep vein thrombosis (DVT) 
and pulmonary embolism (PE), where up to 30% of patients with DVT will die within one month 
of diagnosis and sudden death is the first symptom of 25% of patients with PE.1 In fact, more 
people die each year from complications of DVT than from breast cancer, HIV, and car accidents 
combined.1 Proteins involved in blood coagulation are therefore prime candidates for further 
structural characterization to understand how the vital process of coagulation is maintained in the 
body. 
While biophysical techniques such as X-ray crystallography have been used to obtain 
structural information of blood coagulation proteins, nuclear magnetic resonance (NMR) 
spectroscopy has the unique advantages of investigating proteins in their physiologically relevant 
states and achieving site-specific resolution at sites throughout the protein. Here, the application 
of solution and solid-state NMR spectroscopy to characterize blood coagulation proteins at the 
atomic-scale is presented. In Chapter 2, solution NMR chemical shift assignments for a protein 
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implicated in hemophilia A are reported. Chapter 3 describes the expression and purification of 
one of the primary initiators of the coagulation cascade, human tissue factor (TF), as well as the 
associated solution and solid-state NMR spectra of the optimized sample preparations. Chemical 
shift assignment strategies for tissue factor are discussed in Chapter 4. The use of NMR to access 
information about functionally relevant and dynamic regions in tissue factor is presented in 
Chapter 5. Preliminary investigations into structural characterization of the membrane bound 
form of tissue factor are the focus of Chapter 6.  
 
1.2 Hemostasis and Thrombosis 
1.2.1 The mechanism of blood coagulation 
The process of blood coagulation and its regulation are essential for life. Upon any 
vascular injury, several mechanisms promote hemostasis in the body, which is the process by 
which bleeding is stopped.2 First, blood flow to the affected area is decreased by blood vessel 
constriction at the injured site. Primary hemostasis then occurs, where platelets bind to exposed 
collagen and select membrane proteins on activated endothelial cells, which line the interior of 
blood vessels. A conglomeration of platelets then adheres, forming a loose platelet plug.  The 
blood coagulation cascade, also known as secondary hemostasis, is a series of interactions 
between protein cofactors eventually stabilizes the platelet plug with fibrin filaments. There are 
two pathways for the coagulation process: extrinsic and intrinsic.3 The extrinsic pathway is more 
common and involves TF and its substrate, factor VIIa (fVIIa, other clotting factors are named 
similarly, with “a” signifying the activated form of the clotting factor) versus the intrinsic 
pathway that begins with collagen interacting with fXII. Both the extrinsic and intrinsic 
pathways share a common pathway involving the conversion of prothrombin to thrombin. 
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Thrombin then converts fibrinogen to fibrin to stabilize the platelet plug by self-association of 
fibrin which creates a “web-like gel” to trap white and red blood cells and additional platelets. 
Once the platelet plug is stabilized with fibrin, it is known as a blood clot. Trapped platelets then 
begin to retract initiating tissue repair. The blood clot contracts and is eventually dissolved by 
fibrinolysis involving plasmin-facilitated release of trapped platelets and blood cells. The 
extrinsic pathway of the blood coagulation cascade is depicted in the schematic diagram in 
Figure 1.1. 
  
Figure 1.1. Schematic diagram of the coagulation cascade. The extrinsic pathway of the coagulation 
cascade initiated by fVIIa binding to TF. Of interest are fVIIa in green and TF in magenta, with Ca2+ in 
orange. Fibrin filaments forming at the end of the cascade are labeled as Fbn in tan. Prothrombin and 
thrombin are shown as fII and fIIa, respectively. (Diagram courtesy of Dr. Anna Nesbitt)  
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Understanding how blood clotting is maintained in the body is essential, as roughly 
900,000 people annually in the United States are affected by deep vein thrombosis and 
pulmonary embolism.1 Additionally, certain clotting proteins are implicated in hemophilia A, 
hemophilia B, and von Willebrand disease, the latter of which affects approximately 1.4 million 
people per year in the United States.1 Current therapies designed to treat patients with clotting 
disorders often target a certain part of the clotting process most commonly involving fibrinogen, 
fibrin, or thrombin at the end of the clotting cascade. Heparin, for example, will not dissolve 
clots that have already formed, but it is used regularly in preventing clot enlargement. This 
mechanism accelerates the reactions between antithrombin (thrombin inhibitor) and coagulation 
proteases, thereby preventing the formation of fibrin in blood, which is typically very slow in the 
absence of heparin.4 Additionally, factor replacement therapy and plasma transfusions can be 
used to replace factor deficiencies. An overarching goal of this research is to design specific, 
targeted inhibitors to the TF/fVIIa complex to modulate the clotting process at the beginning of 
the coagulation cascade.  
1.2.2 Tissue factor: primary initiator of coagulation 
TF, also referred to as factor III and thromboplastin, is a 263-residue type-1 integral 
membrane protein that is normally sequestered from the blood, as not to promote clotting where 
there is no injury. Apart from being expressed at sites away from the vasculature, TF has also 
been found in vascular adventitia, mucosal epithelium, cardiac myocytes, renal glomeruli, and 
the cerebral cortex.5 TF acts as a cofactor for the plasma serine protease, fVIIa, which form a 1:1 
complex. fVII circulates at concentrations of 10 nM in the plasma, while its activated form 
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(fVIIa) circulates at 0.1 nM. Although its primary function is in coagulation, TF has also been 
found to play a role in cytokine signaling, inflammation, and apoptosis.6  
TF is a member of the class II cytokine receptor superfamily and is roughly 47 kDa when 
N-glycosylated; however glycosylation has not been found to affect TF function.7 Structurally, 
TF consists of an extracellular domain with two fibronectin type III domains (residues 1-219), a 
single transmembrane helix (residues 220-242), and a cytoplasmic tail (243-263). The bulk of the 
protein is in the extracellular matrix, which is primarily beta sheet in secondary structure, and 
binds fVIIa. The isolated extracellular domain of TF (also known as soluble TF (sTF)) does not 
occur naturally, but because it is highly soluble, has been used in a variety of biophysical studies 
to investigate TF.8,9 Two disulfide bonds (Cys49-Cys57 and Cys186-Cys209) serve to stabilize 
TF.10 TF contains a single-pass transmembrane helix which is valine, isoleucine, and alanine-
rich. The lipid bilayer serves to anchor the TF/fVIIa complex and several TF residues have been 
shown to interact with the membrane.11,12 The cytoplasmic domain is not implicated in 
coagulation and does not affect procoagulant activity13; however, the phosphorylated 
cytoplasmic domain plays a role in cell signaling and metastasis.14,15  
1.2.3 The role of fVIII in coagulation 
fVIII is one of the better-known coagulation factors due to its implication in Hemophilia 
A; patients with the disease have a deficiency of fVIII. Additionally, increased levels of fVIII are 
positively correlated with a higher risk for DVT and PE.16 fVIII is expressed primarily in the 
liver, as well as the kidney and spleen, in its inactive form.17 It circulates in the plasma at a 
concentration of 0.3 nM bound to von Willebrand factor (vWF) and is activated upon cleavage 
by thrombin.18 fVIII is the glycoprotein cofactor for fIXa, which when in complex is responsible 
for the conversion of fX to fXa. fVIII is 370 kDa and consists of a heavy chain (~200 kDa) and a 
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light chain (~80 kDa). The C1 and C2 domains of fVIII modulate membrane binding, which is 
essential for the activation of the fVIIIa-fIXa complex, as well as binding to vWF.19 The fVIII C 
domains are structurally similar to the fV C domains with approximately 45% sequence 
identity.20 
 
1.3 Structural Characterization of Clotting Factors 
X-ray crystallography has long been the gold standard for protein structure determination. 
As of April 2015, there are a total of 108,607 structures deposited in the Protein Data Bank.21 X-
ray crystallography accounts for the vast majority of deposited structures as seen in Figure 1.2. 
The same trend is seen for the crystal structures of all coagulation factors deposited in the PDB 
(Figure 1.2).21 Solution NMR accounts for just 5% of the coagulation factor structure entries; 
solid-state NMR has not been used to solve the structures of any proteins in this category. 
Additionally, several structures of the TF/fVIIa complex with a small molecule inhibitor have 
been solved,22,23 but few structures exist of just TF alone. Several X-ray crystal structures of sTF 
exist at high resolution (Table 1.1);23-26 however, some of these structures lack electron density 
in regions that are hypothesized to bind other coagulation factors. Furthermore, all of the X-ray 
structures reported for TF have been solved with samples in the absence of lipid bilayers. The 
fVIII C2 domain has been studied by X-ray crystallography,19,27,28 electron microscopy,29 
solution NMR30,31 as described in Table 1.2, with partial membrane binding peptide constructs 
used in the solution NMR studies.  
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Figure 1.2. PDB entry statistics.21 (A) Pie chart showing the biophysical techniques used to solve all of 
the protein structures deposited in the PDB as of April 2015. (B) Biophysical techniques used to solve 
blood clotting factor structures.  
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Table 1.1. Current X-ray crystal structures of the extracellular domain of TF* 
   *Deposited in the PDB as of April 2015 
 
Table 1.2. fVIII C2 domain PDB entries* 
           
*Deposited in the PDB as of April 2015 
 
 
Sample Details PDB ID 
Residue 
Count Solved with? Resolution 
Year of 
Release Missing Residues 
Human TF 
extracellular 
Domain25 
2HFT 218 X-ray Diffraction 1.69 1996 
Gly87-Gly90; 
Ser161-Ser162; 
212 to 219 
Human TF 
extracellular 
Domain24 
1BOY 219 X-ray Diffraction 2.20 1996 n/a 
Human TF 
extracellular 
domain23 
1TFH 438 X-ray Diffraction 2.40 1998 Glu84-Ser88 
Rabbit TF26 1A21 438 (2 chains) 
X-ray 
Diffraction 2.35 1998 Asn80-Gly81 
Human TF 
extracellular 
domain/fVIIa 
complex32 
1DAN 175 (sTF) 
X-ray 
Diffraction 2.0 1996 
Ser85-Ala89; 
Lys159-Ser162 
Sample Details PDB ID 
Residue 
Count Solved with? Resolution 
Year of 
Release 
Human C2 
membrane binding 
peptide30 
1CFG 22 Solution NMR - 1995 
Human C2 in 
micelles31 1FAC 21 Solution NMR - 1997 
Human C2 
domain27 1D7P 159 
X-ray 
Diffraction 1.50 1999 
Human C2 
domain19 
3HNY, 
3HOB, 
3HNB 
159, 
318, 159 
X-ray 
Diffraction 
1.07, 2.07, 
1.15 2010 
Porcine C2 
Domain28 4MO3 177 
X-ray 
Diffraction 1.70 2013 
fVIII Light Chain29 3J2S 642 Electron Microscopy 15 2013 
 9 
The highest resolution crystal structures of sTF are shown in Figure 1.3.24,25 Here, it is 
evident that even the highest resolution crystal structure, 2HFT (1.7 Å resolution),25 is missing 
electron density for both dynamic loops that are involved in the allosteric activation of fVIIa (L6, 
residues Pro79-Pro92) and TF membrane interactions (L11, residues Trp158-Lys166). 
Characterizing these loops in atomistic detail will aid in understanding both TF function and 
TF/fVIIa complex formation. B factors, also known as temperature factors, are a measure of 
mobility in high-resolution X-ray crystal structures. Higher B factors are indicative of 
uncertainty in atom position and are often observed in dynamic regions of the protein structure. 
B factors for L6 and L11 are elevated in the 1BOY structure and increase near the boundaries of 
L6 and L11 in the 2HFT structure, further confirming the mobility of these loop regions in sTF. 
 
Figure 1.3. Highest resolution X-ray crystal structures of sTF. (A) The secondary structure elements 
of sTF are labeled (alpha helices: cyan; beta sheets: red; loops: purple) and numbered on the 1BOY 
crystal structure.24 (B) The two highest resolution crystal structures for sTF are shown (1BOY: blue; 
2HFT25: sTF in red plotted on the 1DAN32 structure in complex with FVIIa, grey) with physiologically 
relevant loops L6 and L11 labeled. (C) Close-up of L6 showing missing electron density in the 2HFT 
structure. (D) Close-up of L11 showing missing electron density in the 1DAN structure. 
 10 
1.4 NMR Spectroscopy 
NMR spectroscopy is a unique analytical tool that can characterize molecules and capture 
intermolecular interaction information that is not available using other biophysical techniques. 
NMR exploits the excitation of nuclear spins in a magnetic field to generate a signal, which is 
dependent on the orientations of the spins. NMR active isotopes commonly used in biological 
NMR, such as 1H,13C, and 15N, have a nuclear spin quantum number of ½. In this way, the 
energy of transition of the spins (Em) is proportional to the magnetic field strength (B0) as well as 
the gyromagnetic ratio (γ), which is unique to the spin of interest (Iz) as described in Equation 
1.1. Equation 1.1 can be related to the Larmor frequency (ω) by Equation 1.2.  
    (Equation 1.1)  
     (Equation 1.2) 
The Boltzmann distribution describes the relative populations of nuclei in the two energy 
states, with the amount of nuclei in the lower energy being particularly low, making NMR a 
relatively low sensitivity technique. Critical to the feasibility of NMR and signal-to-noise of the 
spectra are sufficiently strong magnetic field strengths and sample preparation techniques that 
maximize the amount of sample in an NMR tube or rotor. As nuclei are subjected to the 
magnetic field and selective RF pulses, which rotate the magnetization, they relax along the Z-
axis and dephase in the transverse plane. T1, also known as the longitudinal relaxation time, 
refers to the time it takes for the nuclei to relax in the Z-axis, whereas T2, or the transverse 
relaxation time, refers to relaxation in the X-Y plane. The rates of relaxation, R1 and R2, are 
represented as the inverse of the T1 and T2 relaxation times, respectively. Biological samples 
such as proteins are characterized by shorter T2 values, which can cause broader line shapes in 
NMR spectra relative to small molecules.  
Em =  h IzB0
! =  B0
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NMR provides information-rich spectra that report on the local environment of each atom 
in a molecule through chemical shifts. The local environment is described as the perceived 
magnetic field of the nuclei (Equation 1.3), where σ is the chemical shielding constant. 
    (Equation 1.3) 
 
Expressing the chemical shift (δ) in ppm removes the magnetic field dependence of Equation 
1.3, as shown in Equation 1.4. 
   (Equation 1.4) 
 
Nuclear spins obey the time dependent Schrödinger equation and the solid-state NMR 
Hamiltonian can be represented as the sum of HZ (Zeeman term), HCSA (chemical shift 
anisotropy), HCS (chemical shift), HD (dipole-dipole interaction; through space nuclear 
couplings), and HJ (the J-coupling; through bond nuclear couplings). Static solid state NMR 
produces a broad powder pattern, which contains all of the anisotropic terms of the NMR 
Hamiltonian. However, higher resolution can be achieved by spinning the solid sample at the 
magic angle of 54.7º, thereby averaging the dipolar couplings to zero with the resolution 
approaching that of solution NMR. Multiple pulse sequences can then be used to restore the 
dipolar couplings.33  
1.4.1 Protein structure characterization by NMR 
Often, for biological samples, multidimensional spectra are required to uniquely resolve 
chemical shifts for site-specific assignment purposes. Selective isotopic labeling schemes34 can 
further enhance resolution and sensitivity as well as focus in on interesting regions of the 
! =
 B0
2⇡
(1   )
  =
!ref   !signal
!signal
⇥ 106
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molecule. Quantitative NMR is also used to track reaction kinetics and equilibrium dynamics via 
chemical shift perturbations in real-time.35 NMR observables such as relaxation, chemical shifts, 
and dipolar couplings can be used to understand a protein’s structure and dynamics. Using state-
of-the-art NMR techniques, each chemical shift can be assigned to an amino acid in a protein 
leading to site-specific information for atoms in both the protein backbone and side chain. The 
process of protein structure determination using NMR is outlined in the schematic diagram 
below (Figure 1.4).  
 
Figure 1.4. Schematic representation of the NMR chemical shift assignment process. Once spectra 
are acquired and processed, peaks above the noise floor are selected and typed according to amino acid. 
Sequential backbone walks can be used to make connectivities throughout the protein backbone. When 
confirmed, chemical shift assignments can be used to predict the secondary structure of the protein.  
 
Once multidimensional solution and/or solid-state spectra are acquired, signals above the 
noise floor are selected for chemical shift assignment. Each amino acid has characteristic 
chemical shifts, and “spin systems” belonging to a certain amino acid type are then identified. 
Connectivity between amino acids can be made using multidimensional spectra that contain 
different information for polarization transfer pathways along the backbone atoms (N, CA, CB, 
C’) of the protein. The connectivity can then be verified and site-specific assignments are made 
for atoms in the protein. Programs such as TALOSN36 can then predict secondary structure 
elements from chemical shift assignments. Once chemical shift information is obtained and 
Select Peaks Type Amino Acids 
Establish 
Connectivities 
Confirm 
Assignments 
Determine 
Secondary 
Structure 
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confirmed through the chemical shift assignment process, other types of experiments can be 
performed to obtain dynamics information about the protein as a whole as well as site-specific 
dynamics for regions of interest in the protein.  
1.4.2 Solution NMR spectroscopy 
Solution NMR has emerged as an important biophysical structure characterization tool in 
the past decades.37 The first protein structure solved by solution NMR was that of the 57-residue 
bull seminal trypsin inhibitor38, subsequently, solution NMR has been widely used to investigate 
protein structure.39 Solution NMR spectroscopy has been utilized to investigate sTF, and 
chemical shift assignments were reported by the Rienstra group.40 
Applying such methods to insoluble membrane proteins requires the judicious choice of 
detergents, as well as isotopic labeling schemes and pulse sequence methods that have only been 
applied to a limited number of proteins above 30 kDa.41-43 The use of phospholipids for solution 
NMR has recently been realized by the Wagner group.44 However, it remains an immense 
challenge to collect solution NMR data in the presence of physiologically relevant lipids, due to 
the long global correlation times of large lipid-protein complexes.  
1.4.3 Solid-state NMR spectroscopy 
Solid-state NMR is well suited for structure elucidation of membrane proteins and large 
protein complexes. In comparison to X-ray crystallography, solid-state NMR does not require 
single, well-diffracting crystals, which can be very difficult to obtain for membrane proteins.45 
X-ray crystallography structures are also typically solved in the absence of physiologically 
relevant lipids; solid-state NMR enables the study of the protein in its native lipid environment.46 
In comparison to solution NMR, sample for solid-state NMR do not need to be soluble and there 
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is no inherent size limitation on the system to be studied as peak intensities do not depend on the 
molecular weight of the protein.  
Recently developed 3D and 4D magic-angle spinning (MAS) SSNMR spectroscopic 
techniques can provide site-resolution throughout entire uniformly 13C,15N labeled proteins, as 
well as facilitate the chemical shift assignment process. Complete chemical shift assignment has 
been achieved for proteins up to 10 kDa (alpha-spectrin SH3 domain47, ubiquitin48, GB149, 
kaliotoxin50, Crh51, thioredoxin52) and up to 98% of chemical shifts have been assigned for 
proteins up to 20 kDa in size.53-57 Most recently, site-specific resolution throughout the entire 
protein has also been achieved for large systems, most notably, DsbA58, dodecameric helicase59, 
proteorhodopsin60, histones61, and the HIV-1 capsid protein assembly62. The primary bottleneck 
to high throughput structure determination using solid-state NMR is the chemical shift 
assignment process, which is largely done manually.58  
 
1.5 Chapter Overview 
Solution and solid-state NMR have been used to investigate the structure and dynamics 
of functionally relevant blood coagulation proteins. Chapter 2 describes solution NMR chemical 
shift assignment for the membrane-binding C2 domain of fVIII, which is a structural analog for 
the fV C2 domain. The structure of human soluble tissue factor will be investigated in Chapters 3 
and 4. Chapter 3 details the expression and purification conditions for sTF and presents solution 
and solid-state NMR spectra associated with samples of various isotopic labeling patterns,; 
Chapter 4 describes solid-state NMR assignment strategies for two crystal forms of sTF. Chapter 
5 focuses on the dynamics of sTF, using an integrated approach involving solution and solid-
state NMR as well as molecular dynamics simulations. Preliminary spectra of the membrane-
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bound form of TF containing its transmembrane helix are presented in Chapter 6. In all, chemical 
shift assignments and perturbations of the different forms of TF will shed light on the structure of 
TF as well as the mechanism of the TF/fVIIa complex as a whole. 
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CHAPTER 2  
Coagulation Factor VIII C2 Domain Structural Characterization 
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2.2 Abstract 
Factor VIII (FVIII, other clotting factors are named similarly) is a glycoprotein that 
circulates in the plasma bound to von Willebrand factor. During the blood coagulation cascade, 
activated FVIII (FVIIIa) binds to FIXa and activates FX in the presence of calcium ions and 
phospholipid membranes. The C1 and C2 domains mediate membrane binding that is essential 
for activation of the FVIIIa-FIXa complex. Here, 1H, 13C, and 15N backbone chemical shift 
assignments are reported for the C2 domain of FVIII, including assignments for the residues in 
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solvent-exposed loops. The NMR resonance assignments, along with further structural studies of 
membrane-bound FVIII, will advance understanding of blood-clotting protein interactions. 
2.3 Introduction 
In the blood coagulation cascade, FVIII circulates in the plasma bound to von Willebrand 
factor. Following activation by thrombin, FVIIIa binds to the activated plasma serine protease, 
FIXa, on a phospholipid membrane. This FVIIIa/FIXa complex in turn activates FX, and the 
cascade eventually concludes with clot formation. FVIII deficiency or mutation causes 
hemophilia A, a life-threatening bleeding disorder.1 Elucidating the structure and function of 
FVIII will enable more effective treatments to be developed for coagulation disorders. 
FVIII is a glycoprotein cofactor that consists of three ceruloplasmin-like A domains, a B 
domain, and two discoidin-like C2 domains. Despite the similar nomenclature, the C2 domain in 
FVIII is structurally different from the C2 domains found in phospholipases and protein kinase 
C. The FVIII C2 domain is a 163 residue (18.5 kDa) protein located between residues 2170–
2332 of FVIII that will herein be referred to as residues 1–163. Factor V in the blood coagulation 
cascade also contains a discoidin-like C2 domain, which is very similar to the FVIII C2 domain. 
The C1 and C2 domains, within the light chain of FVIII, mediate membrane binding. The C2 
domain binds to membranes containing negatively charged phospholipids under low salt 
conditions. Previous studies have shown that the C2 domain helps to anchor FVIIIa to FIXa in 
the complex; however, it is essential that the C2 domain be attached to the C1 domain to retain 
full FVIII functionality, activity, and membrane affinity.2 
X-ray crystal structures have been solved for the C2 domain of FVIII at resolutions of 1.5 
and 1.07 Å.3,4 The C2 domain consists of a β-sandwich core, with loops of solvent-exposed 
hydrophobic residues,3 and a disulfide bond between Cys5 and Cys157. In particular, a loop 
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formed by Trp144, Val145, and His146, has been found to be involved in C2 membrane 
binding.4 However, site-specific chemical shift assignments have not been reported for the 
isolated C2 domain utilizing solution NMR spectroscopy. Here, we report chemical shift 
assignments for 93% of the backbone atoms of the FVIII C2 domain. 
 
2.4 Materials and Methods 
2.4.1 Recombinant protein expression and purification 
Isotopically labeled FVIII C2 domain was expressed and purified as in Novakovic et al.2 
The FVIII C2 construct (residues Gly1 to Tyr163), including a N-terminal thrombin cleavage site 
and a His6 tag, was cloned into ampicillin-resistant pET21 with a N-terminal thioredoxin tag. 
The plasmid was transformed into BL21(DE3) Escherichia coli cells (Novagen). Cells were 
grown in LB (Luria–Bertani) broth supplemented with 100 µg/mL of ampicillin. The cells were 
grown at 37°C to an OD600 of 0.7. Expression was induced with 50 µM isopropyl β-D-1-
thiogalactopyranoside for 5 h. The cells were harvested via centrifugation and the pellets were 
frozen overnight at −20°C. The cells were thawed and resuspended in B-PER (Bacterial Protein 
Extraction Reagent, Pierce Chemical) to lyse the cells. The lysate was centrifuged at 15,000 rpm 
for 45 min at 4°C, sonicated, and filtered. 
The C2 domain was purified using Ni2+ affinity chromatography with a 10 mL Ni–NTA 
column (Qiagen). The protein was eluted from the column with a gradient of 4, 8, 30, 60 and 
200 mM imidazole in 150 mM NaCl, 20 mM Tris/HCl pH 7.5. Active fractions were tested with 
LabChip BioAnalyzer (Agilent Technologies). The His6 and thioredoxin tags were cleaved from 
the protein by incubating with 0.0175 mg human alpha thrombin (Enzyme Research 
Laboratories, South Bend, IN) per 1 mg of protein overnight at 37°C. The thrombin was 
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inactivated with 3:1 PPACK (D-Phe-Pro-Arg-chloromethylketone), and the extent of cleavage 
was assessed using SDS-PAGE gel electrophoresis. The protein was concentrated using Amicon 
Ultra (Millipore) with a molecular weight cut-off of 10 kDa, but not under 2 mL as it has a 
tendency to precipitate out of solution at high concentrations (>0.15 mM) under these buffer 
conditions. The protein was then buffer-exchanged into 5 mM MES, 25 mM NaCl pH 5.5. 
Cation-exchange chromatography, using a 1 mL HiTrap SP HP column (GE Healthcare), 
removed the thrombin and cleaved tags from the protein. The C2 domain was eluted from the 
column with 0.2 mM NaCl in 20 mM HEPES pH 8.0. Active fractions were pooled and 
concentrated and the purity of the protein was determined to be greater than 98% using the 
LabChip Bioanalyzer. Yields for the expression and purification were 5 mg of protein per 
400 mL of cell culture. Backbone resonances of FVIII-C2 were assigned using a 0.8 mM 
13C,15N-labeled sample at 298 K in 50 mM NaCl, 50 µM EDTA, 0.01% NaN3, and 20 µM DSS, 
10% D2O, 10 mM imidazole, pH 6.05. 
2.4.2 Solid-state spectroscopy 
Backbone chemical shift assignments were made using 1H–15N TROSY-HSQC, TROSY-
HNCO, TROSY-HNCA, TROSY-HNCACB, and TROSY-HNCOCACB spectra. Spectra were 
acquired on a Bruker 600 MHz spectrometer with a triple-resonance (1H-13C-15N) probe. Spectra 
were processed using NMRPipe5 and were analyzed in Sparky.6 TALOS+ was used to predict 
the secondary structure elements of the C2 domain as well as the order parameter.7 
 
2.5 Results and Discussion 
We assigned 93% of the backbone HN, N, C′, Cα, and Cβ atoms using a suite of 3D 
TROSY-based spectra. These chemical shift assignments include 94% of the HN resonances, 
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94% N, 95% Cα, 95% Cβ, and 86% C′. In the 1H-15N TROSY-HSQC (Figure 2.1), 143 of the 
expected 155 peaks were assigned. Complete or near complete backbone assignments were made 
for all of the residues in the C2 domain, with the exception of the N-terminal residues Gly1-Met4 
and residues Pro130 and His140, which precede proline residues. The N-terminal residues are 
also in a flexible region of the protein, and the peaks were missing in the acquired spectra. The 
chemical shifts have been deposited in the BioMagResBank (BMRB) under accession number 
17829. 
 
 
Figure 2.1. 1H-15N TROSY-HSQC of the FVIII C2 domain. A 2D 1H-15N TROSY-HSQC spectrum of 
the FVIII C2 domain acquired at 600 MHz. Assignments were made for 143 of the expected 155 
resonances. The resonance of residue Trp34 is folded in the 15N dimension.  
Figure 2.2 shows the predicted secondary structure and the order parameters of the C2 
domain using the chemical shift index8 and backbone torsion angles predicted by TALOS+.7 As 
 26 
seen in Figure 2.2, several regions of the protein are disordered with low order parameter values 
(<0.8) and the corresponding residues are all found in loops or at boundaries of structured 
regions of the protein. 
 
 
Figure 2.2. fVIII C2 domain order parameters. Predicted order parameter values and secondary 
structure elements of the FVIII C2 domain using TALOS+.7 Residues having a probability of at least 0.5 
of exhibiting α-helical (negative) or β-sheet (positive) character are displayed. 
 
Pratt et al. show that the FVIII C2 domain structure contains 19 β-strands, 8 of which 
form a β-sandwich core fold (PDB ID: 1D7P).3 Additionally, two α-helices are at the N-terminus 
of the domain. Loops formed by Met10-Phe11, Gln53-Lys58, Leu82-Leu86, and Trp144-His146 
contribute to FVIII C2 domain binding to membranes.3,4 As seen in Figure 2.2, these residues are 
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either in at the boundary of a secondary structure element or in an unstructured region of the 
protein. There are eight C-terminal β-strands from the TALOS+ prediction, consistent with the 
primarily β-sheet structure observed in the X-ray crystal structures (PDB ID: 1D7P, 3HOB, 
3HNY, 3HNB).3,4 Almost all the differences between the X-ray structure, 1D7P, and the 
experimental NMR data could be attributed to crystal packing interactions, except for residues 
Ser35–Arg40 that instead may arise from the different constructs used or different sample 
preparation conditions (Figure 2.3). 
 
 
Figure 2.3. Secondary structure of the FVIII C2 domain. (A) Comparison of secondary structure 
elements between experimental NMR data (red) and X-ray crystal structure 1D7P (cyan) using DSSP.9 
Underlined residues indicate differences in 1D7P that include an N-terminal xLNSGSHM extension and a 
Ser127Cys mutation. (B) Comparison of secondary structure elements between experimental NMR and 
the X-ray crystal structure using the DSSP algorithm in Chimera.10 The crystal structure is shown 
in cyan and regions where the solution NMR structure differs are shown in red. 
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3.2 Abstract 
In normal hemostasis, the blood clotting cascade is initiated when factor VIIa (fVIIa, 
other clotting factors are named similarly) binds to the integral membrane protein, human tissue 
factor (TF). The TF/fVIIa complex in turn activates fX and fIX, eventually concluding with clot 
formation. Several X-ray crystal structures of the soluble extracellular domain of TF (sTF) exist; 
however, these structures are missing electron density in functionally relevant regions of the 
protein. In this context, NMR can provide complementary structural information as well as 
dynamic insights into enzyme activity. The resolution and sensitivity for NMR studies are 
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greatly enhanced by the ability to prepare multiple milligrams of protein with various isotopic 
labeling patterns.  Here, we demonstrate high-yield production of several isotopically labeled 
forms of recombinant sTF, allowing for high-resolution NMR studies both in the solid and 
solution state. We also report solution NMR spectra at sub-mM concentrations of sTF, ensuring 
the presence of dispersed monomer, as well as the first solid-state NMR spectra of sTF. Our 
improved sample preparation and precipitation conditions have enabled the acquisition of 
multidimensional NMR data sets for TF chemical shift assignment and provide a benchmark for 
TF structure elucidation.  
 
3.3 Introduction 
Proteins involved in the blood coagulation cascade are of vital biomedical importance, 
and understanding the mechanism of blood clotting protein interactions is crucial to the 
continued development of successful treatments for blood coagulation disorders such as 
hemophilia, von Willebrand disease, and thrombosis. The blood clotting cascade is initiated 
through the extrinsic pathway when the activated serine protease, factor VII (fVIIa), binds to 
human tissue factor (TF) (Factors are named with Roman numerals and the suffix “a” to indicate 
the activated state.).1 A series of other clotting factors are subsequently activated; for example, 
the membrane-bound TF/fVIIa complex in turn activates fX and fIX via limited proteolysis, and 
the cascade eventually concludes with clot formation. 
Human TF is a type-I integral membrane protein that is expressed on the surface of cells 
outside the vasculature.2 It is a member of the class II cytokine receptor superfamily and consists 
of three domains: the extracellular domain (residues 1-219), a membrane spanning helix 
(residues 220-242), and the cytoplasmic domain (residues 243-263). The extracellular domain 
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comprises two fibronectin type-III domains, which have primarily β-sheet secondary structure. 
The isolated extracellular domain of TF (also known as soluble TF, sTF) does not occur 
naturally, but because it is highly water soluble while retaining the ability to form an active 
enzyme complex with fVIIa,3 it has been used in a variety of biophysical studies to investigate 
TF.4-9 Apart from blood coagulation, TF has also been implicated in a variety of processes, 
including inflammation, metastasis, and cell signaling.10 
The structure of sTF has been characterized using X-ray crystallography and solution 
NMR spectroscopy.6-9,11 Several X-ray crystal structures of sTF exist at high resolution (1.69-
2.40 Å);6-8 however, some of these structures lack electron density in regions that are 
hypothesized to interact with fVIIa, fIX, fX, and the membrane bilayer. Solution NMR 
spectroscopy has been utilized to investigate sTF, and Boettcher et al report site-specific 
chemical shift assignment for 90% of the protein backbone, including 97% of the amide 
resonances.11  
Solid-state NMR enables the study of membrane proteins in their native lipid 
environment. Additionally, there is no fundamental limit on the molecular weight of the protein, 
although larger proteins present data interpretation challenges. In solution NMR, the slow 
tumbling times of the protein prohibit larger molecules from being studied; however, in the solid 
state, linewidths and peak intensities do not depend on the molecular weight of the protein. 
Solid-state NMR also does not require single crystals as would be needed in X-ray 
crystallography. Recently developed 3D and 4D magic-angle spinning (MAS) solid-state NMR 
spectroscopic techniques can provide site-resolution throughout entire uniformly 13C,15N-labeled 
proteins, as well as facilitate the chemical shift assignment process.12-16 
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A protocol for the expression and purification of 15N-labeled sTF employing S. cerevisiae 
or inclusion bodies from E. coli has been reported.9 We now report a highly efficient protocol for 
expression and purification of doubly- and triply- (2H, 13C, 15N) labeled sTF in the periplasmic 
space of E. coli, which allows for the formation of disulfide bonds, thereby obviating the need 
for protein refolding as previously described.9 As both solution and solid-state NMR require 
milligram quantities of pure protein for spectral acquisition, a robust and effective expression 
and purification protocol for this system is crucial for sTF structural characterization using 
NMR. Here, we utilize solid-state NMR to evaluate sTF samples as a precursor to examining the 
TF structure as a whole and demonstrate the benefits of uniform and skip-labeling schemes on 
spectral resolution and sensitivity. 
 
3.4 Materials and Methods 
3.4.1 Expression of doubly-labeled (13C,15N) recombinant sTF 
Media used for the expression of each variety of isotopically labeled sTF described in this 
study are listed in Table 3.1. All flasks and media were autoclaved or filter-sterilized where 
applicable prior to use. A C-terminal His-tagged construct of sTF was cloned into plasmid 
pJH677 with kanamycin resistance and expressed using T7 Express E. coli cells (New England 
BioLabs, Inc., Ipswitch, MA, USA). A glycerol stock of transformed cells was used for all 
subsequent expressions. The sTF glycerol stock was grown on a Luria Broth (LB) agar plate 
containing 50 µg/mL kanamycin and incubated for ~15 hours at 37 °C. A single colony was 
inoculated into 25 mL modified Studier17 media (MDG) in a 250 mL baffled flask and grown for 
7 hours at 37 °C at 300 rpm. The preculture (1 mL) was added to 250 mL MDG in a 2-L baffled 
flask and grown for ~12-15 hours at 37 °C at 300 rpm until the A600 of the culture was between 
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5-7. The cells were harvested by centrifugation for 20 minutes at 25 °C at 7000 x g and were 
subsequently resuspended in 1-L MBG modified Studier media with BioExpress (Cambridge 
Isotope Laboratories, Inc., Andover, MA, USA) as given in Table 1, to achieve a resulting A600 
of ~2.  The culture was divided into four 2-L flasks and grown for ~30 minutes at 25 °C at 300 
rpm until an A600 of ~3 was reached to deplete any remaining natural abundance isotopes. 
Expression of sTF was induced with isopropyl β-D-1-thiogalactopyranoside (IPTG) at a final 
concentration of 100 µM for 24 hours at 25 °C. Cells were harvested via centrifugation for 35 
minutes at 25 °C at 8500 x g. The cell pellets were stored at -80 °C prior to purification. 
3.4.2 Expression of triply-labeled (2H,13C,15N) recombinant sTF 
Triply-labeled (2H,13C,15N) sTF samples were prepared following a modified expression 
protocol. The cells were conditioned to grow and express in D2O by slowly ramping up the 
fraction of D2O in the medium. LB (5 mL) containing 100 ug/mL kanamycin was inoculated 
with the sTF glycerol plasmid stock and shaken for 7 hours at 37 °C at 300 rpm. The LB growth 
(1 mL) was inoculated into 25 mL of ~80% deuterated MDG and shaken for 12 hours at 37 °C at 
300 rpm. Then, 1 mL of the ~80% deuterated MDG was inoculated into 25 mL of 90% 
deuterated MDG and shaken for ~12 hours at 37 °C at 300 rpm. The ~90% deuterated MDG 
culture (10 mL) was added to 500 mL of 100% deuterated MDG and divided between two 2-L 
baffled flasks and grown for ~15 hours at 37 °C at 300 rpm until an A600 of ~4-5 was reached.  
The cell culture was centrifuged for 15 minutes at 20 °C at 6500 x g prior to being 
resuspended in 1 L of ~100% deuterated MBG. The resuspended culture was then divided into 
four 2-L baffled flasks and grown for ~1 hour at 25 °C at 300 rpm until an A600 of ~3 was 
reached. Expression of sTF was induced with IPTG at a final concentration of 100 µM for 24 
hours at 25 °C. Cells were harvested by centrifugation for 15 minutes at 20 °C at 7500 x g. 
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Other deuterated preparations were grown in this step-wise approach (from 0% 
deuteration to ~80% deuteration to ~90% deuteration to ~100% deuteration precultures into 
~100% deuteration for expression media) in order to condition the cells for growth in deuterium 
prior to the introduction of 13C and 15N and induction of expression. 
3.4.3 Expression of skip-labeled recombinant sTF using 1,3-13C-glycerol or 2-13C-glycerol 
Skip-labeled samples were prepared using a protocol highly similar to that of the uniform 
13C,15N expression. Notably, in the final 250 mL MDG culture, the unlabeled glucose was 
replaced with natural abundance glycerol so that the cells could condition to using glycerol as the 
carbon source. In the expression medium, cells were grown using the modified Studier media 
(MGG) instead of MBG. This replaces the glucose with isotopically labeled glycerol and also 
excludes the BioExpress, which can only be used in uniformly labeled expressions. MGG 
contains 0.5% 1,3-13C glycerol and 0.25% 12C sodium carbonate or 0.5% 2-13C glycerol and 
0.25% 13C sodium carbonate.18 
3.4.4 Purification of isotopically labeled recombinant sTF 
 Frozen cell pellets from 250 mL culture were rapidly thawed at 37 °C and resuspended 
in 20 mL of 20% sucrose in 50 mM sodium phosphate (pH 7.5) buffer, 50 mM NaCl. The cells 
were shaken at 4 °C at 200 rpm for 10 minutes. Cells were centrifuged for 35 minutes at 4 °C at 
7500 x g and the supernatant was collected. The cell pellets were then rapidly resuspended in 20 
mL MilliQ ultrapure water to release sTF from the cells via osmotic shock. The cells were 
shaken for 10 minutes at 4 °C at 200 rpm. MgCl2 (final concentration = 1 mM) and 
Turbonuclease (Accelagen, San Diego, CA, USA; final concentration = 25 units/mL) were added 
and incubated for 1 hour at 25 °C. The cells were centrifuged for 1 hour at 4 °C at 8500 x g. The 
supernatant was combined with the supernatant from the resuspension in 20% sucrose. Q-
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Sepharose® Fast Flow ion exchange media (Sigma-Aldrich, St. Louis, MO, USA) were 
equilibrated with five changes of 50 mM sodium phosphate buffer (pH 7.5) and 50 mM NaCl 
(250 mL) and collected by vacuum filtration. Equilibrated Q-Sepharose beads were added to the 
supernatant at 1 g beads per 10 mL of supernatant and rotated for 40 minutes at 4 °C. The 
supernatant was collected by vacuum filtration and 0.02% NaN3 was added.  
Ni2+ affinity chromatography was then used to further purify the supernatant. Two 5 mL 
HisTrap™ Fast Flow columns (GE Healthcare, Piscataway, NJ, USA) were equilibrated with 
five column volumes (50 mL) of binding buffer (25 mM sodium phosphate (pH 8) buffer, 300 
mM NaCl, 20 mM imidazole (pH 8)). NaCl (final concentration = 300 mM) and imidazole, pH 8 
(final concentration = 20 mM) were added to the supernatant, which was subsequently filtered 
using a 0.45 µm membrane filter. The supernatant was loaded on the affinity columns and the 
columns were washed with 5-10 changes of binding buffer to remove any weakly bound protein. 
sTF was eluted as a single sharp peak (monitored by A280) with 25 mM sodium phosphate (pH 8) 
buffer, 300 mM NaCl, 500 mM imidazole (pH 8). Pure sTF was concentrated using Centriprep™ 
centrifugal filter concentrators (EMD Millipore, Billerica, MA, USA) with a molecular weight 
cutoff of 10 kDa. The concentrated sTF was dialyzed against three changes of 50 mM sodium 
phosphate (pH 7.5) buffer, 50 mM NaCl, 0.01% NaN3 (1.33 L) to eliminate excess imidazole.  
Yields of uniform 13C,15N sTF were 60-100 mg protein per liter of media. Yields of 
deuterated 1,3-13C glycerol and 2-13C glycerol sTF were >80 mg protein per liter media. Thus, 
deuteration and/or glycerol growth did not seem to adversely impact the purified protein yield. 
SDS-PAGE gel electrophoresis was performed using 12% acrylamide gels run at a constant 
voltage of 120 V for 90 minutes with Tris-glycine running buffer.  
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3.4.5. FVIIa amidolytic assay 
The cofactor activity of sTF was measured throughout the purification using the fVIIa 
amidolytic assay as previously described.5 Briefly, 25 mM HEPES (pH 7.4), 100 mM NaCl, 5 
mM CaCl2, 0.1% bovine serum albumin, 5 nM fVIIa (Sekisui Diagnostics, Lexington, MA, 
USA) and varying concentrations of sTF were added to each well of a 96-well plate. The 
reaction began upon addition of 1 mM Chromozym t-PA substrate (Roche Diagnostics, 
Indianapolis, IN, USA) to each well and the rate of substrate hydrolysis was quantified by 
measuring the change in A405 for 20 minutes at 25 °C. 
3.4.6. Solution NMR Spectroscopy 
Purified sTF samples were dialyzed using Slide-A-LyzerTM dialysis cassettes (Life 
Technologies, Grand Island, NY, USA) with a molecular weight cutoff of 10 kDa against three 
changes of 50 mM sodium phosphate (pH 6.5), 50 mM NaCl (1.33 L). Following dialysis, the 
buffer was adjusted to contain 10% D2O and 0.01% NaN3 and sTF was concentrated to ~550 µL 
using Centriprep™ centrifugal filter concentrators. For samples used for assignment purposes,11 
1 mM 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) was added. Spectra were processed with 
NMRPipe19 and analyzed in Sparky.20 
3.4.7. Magic-angle spinning (MAS) solid-state NMR spectroscopy 
Two methods were used to precipitate purified sTF for solid-state NMR. The first used 
polyethylene glycol (PEG), in which sTF samples were precipitated after dialysis with 5-20% 
PEG 3350 in 25 mM sodium phosphate (pH 7.5) buffer for ~12 hours at 20 °C. The second used 
ammonium sulfate, in which sTF was precipitated with ammonium sulfate (final concentration = 
~1.8 M) in 100 mM HEPES (pH 7.5) buffer, 200 mM NaCl, 5 mM Cu-EDTA. The precipitated 
material was incubated for ~12 hours at 4 °C and then ultracentrifuged for 2 minutes at 25 °C at 
 38 
10,000 x g. X-ray powder diffraction (XRD) was used to identify ammonium sulfate in the 
ammonium sulfate-precipitated sTF samples for solid-state NMR (Figure 3.1), and the 
experimental powder pattern (black) overlays well with the theoretical ammonium sulfate pattern 
(red). While the experimental spectrum overlays well with the theoretical spectrum for 
ammonium sulfate, protein reflections (from ~ 0 to 4 °) could not be detected.  
 
Figure 3.1. X-ray diffraction spectrum of ammonium sulfate-precipitated sTF. The X-ray powder 
diffraction pattern of 1.8 M ammonium sulfate-precipitated sTF (black) with the overlay of the 
ammonium sulfate powder pattern (red). The spectrum was acquired on a Bruker D8 Venture with copper 
radiation equipped with a PHOTON 100 detector at 25 °C.  
 
Samples were packed into 3.2 mm standard and limited speed NMR rotors (Agilent 
Technologies, Santa Clara, CA, USA). Spectra were acquired on a Varian/Agilent VNMRS 11.7 
T (500 MHz 1H frequency) spectrometer with a 1H-13C-15N 3.2 mm Balun T3 probe and a 
Varian/Agilent VNMRS 17.6 T (750 MHz 1H frequency) spectrometer with 1H-13C-15N 3.2 mm 
BioMAS probe.21 2D 13C-13C correlation spectra were acquired at 10 °C and used tangent 
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ramped cross polarization22 with SPINAL-64 decoupling23 and DARR mixing.24 2D 15N-13C 
correlation spectra were acquired at -5 °C and used tangent ramped cross polarization22 with 
SPINAL-64 decoupling.23 Spectra were processed with NMRPipe19 and analyzed in Sparky.20 
 
3.5 Results & Discussion 
3.5.1 Isotopically labeled sTF expression & purification 
A previous sTF expression and purification protocol required protein refolding from E. 
coli inclusion bodies.9 In our protocol, we utilized MDG media in order to facilitate E. coli 
growth to high optical density and produce healthy cultures that are stable for day-long time 
periods, leading to a robust sTF expression method without the need for carefully monitoring cell 
growth in the mid-log phase. Growing cells in MDG to saturation (A600 of ~5-7) produced high 
cell density, which yielded high expression upon IPTG induction when the bacteria were 
resuspended in fresh isotopically labeled media. This technique boosted protein yields while 
minimizing the use of expensive isotopically labeled reagents. Expression of sTF in the 
periplasmic space allows for native folding and disulfide bond formation, thereby eliminating the 
need for protein refolding.25 Additionally, this method enabled improvement in yields of up to 
100 mg per liter of uniform 13C,15N, pure sTF. This is a factor of 100 increase in yield from our 
previously published natural abundance sTF expression and purification method.25 Additionally, 
this is a 50% increase in yield of 15N labeled sTF from the refolding protocol in Stone et al.9 
Yields of skip-labeled sTF samples have not been reported previously in the literature. The 
relative purity at each phase of the purification is illustrated in the SDS-PAGE gel of sTF in 
Figure 3.2, indicating a very high level of purity in the concentrated sTF sample (Lane 7). 
 40 
Purified sTF retained full cofactor activity towards fVIIa, as measured by the fVIIa amidolytic 
activity assay,5 with a percent activity of 101.0 ± 3.9 % relative to a standard sTF sample. 
 
 
Figure 3.2. SDS-PAGE analysis of sTF purification. SDS-PAGE 12% acrylamide gel of sTF samples 
stained with Coomassie Brilliant Blue R-250 showing: Lane 1: Precision Plus ProteinTM Dual Color 
marker (Bio-Rad, Hercules, CA, USA); Lane 2: water and sucrose combined supernatant; Lane 3: Q-
Sepharose® Fast Flow supernatant; Lane 4: Post 0.45 µm filter; Lane 5: pre-load on Ni2+ affinity column; 
Lane 6: 500 mM imidazole elution; Lane 7: concentrated sTF. 
 
 
3.5.2 Analysis of solution and solid-state NMR spectra  
The 1H-15N 2D HSQC correlation spectrum of 100 µM sTF is shown in Figure 3.3. 
Previously, our group assigned the majority of the resonances using ~1 mM sTF samples;11 
however, sample lifetime is enhanced by utilizing 100 µM sTF concentrations, and the relative 
signal intensities throughout the spectrum are more consistent than the 1 mM sTF sample, 
indicating the presence of a pure, monodisperse sample. The fingerprint spectrum shown in Fig. 
2 demonstrates a common fold with prior solution NMR studies.9,11 
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Figure 3.3. 1H-15N 2D HSQC correlation spectrum. Solution NMR fingerprint spectrum of 100 µM 
uniform 13C,15N sTF in 50 mM sodium phosphate (pH 6.5), 50 mM NaCl, 5% DSS, 10% D2O, 0.1% 
NaN3 acquired at 35 °C on a Varian/Agilent VNMRS 17.6 T (750 MHz 1H frequency) spectrometer.  
 
Solid-state NMR samples of sTF were prepared by precipitation with either PEG or 
ammonium sulfate. PEG offers the advantage of lower ionic strength in the NMR sample, 
whereas ammonium sulfate may compromise performance for certain types of NMR probes.21 
However, the PEG-precipitated samples yielded substantially lower quantities of protein in the 
pellet (packed in the NMR rotor), as determined by quantitative 13C NMR, and showed high 
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variability in the yield. Specifically, the PEG-precipitated samples varied from 5% to 20% sTF 
by mass in the pellet. In contrast, the ammonium sulfate-precipitated samples yielded ~70% sTF 
by mass in the pellet, and several preparations of this form showed a consistent yield.  
Utilizing low electric field resonators21 allowed for the acquisition of high-resolution, 
multidimensional solid-state NMR data sets using the ammonium sulfate-precipitated sTF 
samples. The 13C-13C 2D correlation spectra with DARR mixing are shown in Figure 3.4.  
Figure 3.4. Solid-state 13C-13C 2D correlation spectra of uniform 13C,15N sTF. (A) 13C-13C 2D 
correlation spectrum with 25 ms of DARR mixing of ~15 mg sTF precipitated with 15% PEG 3350 
acquired at 750 MHz (1H frequency) for 12 hours with a MAS rate of 12.5 kHz at a variable temperature 
set point of 0 °C. (B) 13C-13C 2D correlation spectrum with 50 ms of DARR mixing of ~31 mg sTF 
precipitated with 1.8 M ammonium sulfate and 5 mM Cu-EDTA acquired at 750 MHz (1H frequency) for 
24 hours with a MAS rate of 12.5 kHz at a variable temperature of -5 °C. Both spectra were processed 
with 20 Hz of Lorentzian-to-Gaussian line broadening in each dimension, sine bell apodization, and zero 
filled 8192 points in the direct (F1) dimension and 4096 in the indirect (F2) dimension with contours 
drawn at 6 times the noise floor. 
 
The ammonium sulfate-precipitated sample exhibits substantially better resolution than 
the PEG-precipitated sample, which we attribute to the greater regularity of crystal formation 
under these conditions. Additionally, the ammonium sulfate-precipitated sample exhibits 
inhomogeneous linewidths of less than 0.1 ppm, and the signal-to-noise ratios for the one-bond 
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correlations are >30:1 in 24 hours. By comparison, the PEG-precipitated sample is less well-
resolved, particularly in the Thr CA-CB region highlighted in Figure 3.4, which is diagnostic of 
sample homogeneity. Because scalar couplings contribute to the majority of the linewidth in the 
case of the ammonium sulfate-precipitated sample, additional enhancements in resolution are 
achievable by using skip-labeling, as shown in Figure 3.5. Table 3.2 lists 15N and 13C linewidths 
for selected sTF resonances from the uniform 13C,15N and 2-13C glycerol, 2H,15N samples. In 
particular, selective isotopic labeling reduces the 13C linewidths by approximately a factor of 2 
across all the resonances listed.  
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Figure 3.5. Solid-state 15N-13CA correlation spectra of uniform and skip-labeled sTF. (A) 15N-13CA 
correlation spectrum of ~30 mg of uniform 13C,15N ammonium sulfate-precipitated sTF with 5 mM Cu-
EDTA. The spectrum was acquired for 3 hours and 20 minutes with an acquisition time of 25 ms. (B) 15N-
13CA correlation spectrum of ~25 mg of 2-13C glycerol, 2H, 15N ammonium sulfate-precipitated sTF with 
5 mM Cu-EDTA. The spectrum was acquired for 3 hours with an acquisition time of 30 ms. Both spectra 
were collected at 750 MHz (1H frequency) at a variable temperature of -5 °C with a MAS rate of 12.5 
kHz. Both spectra were processed with 10 Hz of Lorentzian-to-Gaussian line broadening in each 
dimension, sine bell apodization, and zero filled 8192 points in the direct (F1) dimension and 2048 in the 
indirect (F2) dimension with contours drawn at 6 times the noise floor. 
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Table 3.2. Linewidth analyses for ammonium sulfate-precipitated sTF 
 
15N and 13C linewidths and signal to noise ratios are presented for representative peaks in the 
uniform 13C,15N sTF and skip-labeled, deuterated sTF 15N-13CA correlation spectra shown in 
Figure 3. 
Chemical Shift Uniform 13C,15N sTF 2-13C glycerol, 2H,15N sTF 
15N 
(ppm) 
13C 
(ppm) 
Signal 
to 
Noise 
15N Linewidth 
(Hz) 
13C Linewidth 
(Hz) 
Signal 
to 
Noise 
15N Linewidth 
(Hz) 
13C Linewidth 
(Hz) 
113.36 
 
55.38 
 
21 
 
47.3 
 
64.5 
 
25 
 
44 
 
47.7 
 125.89 
 
55.9 
 
53 
 
60.2 87.6 33 41.6 45.2 
126.59 60.61 34 49.2 93.2 10 54.4 47.2 
112.43 58.49 37 63.5 113.6 16 40.6 58.6 
117.42 54.53 45 34.2 63.8 27 34.3 49.6 
130.45 55.01 33 52.7 89.2 12 38.2 63.3 
127.94 61.74 23 85.5 167.5 13 72.2 76.9 
111.84 61.92 58 53.5 81.4 14 37.7 51.4 
114.91 55.39 22 67.6 120.8 11 50.5 51.6 
123.23 52.22 30 59.7 93.8 10 48.1 50.9 
111.95 61.98 58 50.7 85.2 11 32.4 39.3 
108.33 57.17 25 50.9 78.5 20 39.3 42.6 
114.89 60.18 37 115.7 100 29 37.1 42.9 
110.44 54.25 53 55.5 98.7 29 35.1 50.6 
105.05 58.19 28 50.8 85.2 17 33.5 31.9 
108.34 59.25 31 62.1 95.4 22 27.9 41.4 
125.38 51.02 30 74 96 25 43.7 36.5 
119.02 55.5 47 75.4 152.7 23 54.5 75.4 
113.11 59.91 18 66.8 102.9 7 38.7 29.1 
117.95 52.34 12 84.9 97 6 38.2 57.8 
116.59 54.83 26 187.3 187.7 19 72.4 71.3 
129.92 50.96 28 53.7 91.4 22 38.6 36.2 
124.4 54.87 44 47.3 86.8 14 41.1 40.6 
126.3 61.88 37 47.1 79.7 15 40.4 34.1 
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3.6 Conclusions 
NMR provides unique opportunities to investigate atomistic details of blood coagulation, 
including structure, interactions, and dynamics. Towards this end, we have developed greatly 
improved methods for expression and purification of isotopically labeled, active sTF that enable 
highly resolved spectra to be collected using both solution and solid-state NMR. We have also 
greatly increased the sensitivity of solid-state NMR measurements of sTF, by increasing the 
fraction of protein in the pellet using ammonium sulfate precipitation. This procedure yields a 
factor of at least 3 to 5 increase in sensitivity relative to the PEG precipitation, yet both forms 
give highly similar chemical shifts, indicating a common fold. Further, skip-13C-labeling of sTF 
greatly enhances the sensitivity as well as resolution for multidimensional solid-state NMR 
studies. Chemical shift data can now be compared between the soluble and crystalline forms of 
TF, and perturbations will shed light on the structure of sTF and ultimately the structure and 
mechanism of the TF/fVIIa complex. 
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CHAPTER 4  
Solid-state NMR Assignment Strategies for Two sTF Crystal Forms 
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4.2 Abstract 
NMR is a powerful analytical tool that reports with atomistic detail on the local chemical 
environment of a system. In order to eventually glean mechanistic data from NMR spectra, the 
chemical shifts in each spectrum must first be assigned. The process of NMR chemical shift 
assignment is quite rigorous involving challenging isotopically labeled sample preparation 
techniques, spectral acquisition, and substantial data analysis. Here, solid-state chemical shift 
assignments for PEG and ammonium sulfate-precipitated sTF are presented. NMR-derived 
secondary structure elements and order parameters are predicted using TALOS-N. Finally, NMR 
restraints are incorporated into joint refinement structure calculations to more fully understand 
the structure of sTF in comparison to the existing X-ray crystal data.  
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4.3 Introduction 
In order to investigate a molecule’s structure and function, its NMR chemical shifts must 
first be assigned. Solution NMR spectroscopy has experienced significant methodological 
advances in the chemical shift assignment of proteins.1,2 Assignment algorithms such as PINE3 
enable complete automated assignment from spectral peak lists and the protein sequence. 
Analogous experiments exist in the solid-state for protein chemical shift assignment. Programs 
such as MCASSIGN24, PLUQ5, and NSGA-II6 provide automated assignment options for solid-
state NMR; however, to date, chemical shift assignment is largely done manually in the solid-
state.   
Chemical shift assignment strategies involve isotopic labeling of protein samples, 
significant data collection, and data analysis to make interresidue connections between atoms. 
Significant advances in sample preparation techniques, most notably, the introduction of isotopic 
labeling patterns,7 have facilitated the chemical shift assignment process. However, the process 
is often quite iterative involving several different sample preparations and the acquisition of 
selective experiments for the purpose of completing chemical shift assignment. Typically, 
acquiring a 13C 1D spectrum provides a rapid and efficient way to roughly assess sample quality 
and determine the amount of protein in the NMR rotor. However, for proteins, a 1D spectrum 
does not provide sufficient resolution for specific chemical shift assignment regardless of the 
sensitivity of the sample. In order to resolve individual peaks, 2D spectra and often 3D spectra 
are necessary to provide higher resolution of peaks and even then each peak may not be baseline 
resolved due to spectral degeneracy of large proteins.  
Acquisition of a 13C-13C 2D correlation spectrum is a natural next step if a 1D spectrum 
does not exhibit baseline resolution. This experiment is analogous to a solution NMR 1H-15N 
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HSQC and provides a “fingerprint” of the amino acids in the protein. As each amino acid, has a 
characteristic set of chemical shifts (some of which are unique), amino acid chemical shifts will 
be grouped according to residue type in the 13C-13C 2D correlation spectrum. In particular, Thr 
and Ser residues are isolated from other amino acid chemical shifts, making them easily 
identifiable in a 2D spectrum. In fact, several spin systems can be identified from the 13C-13C 2D 
of sTF with 25 ms DARR8 mixing, but spectral degeneracy remains a problem. Selective isotopic 
labeling schemes, including skip labeling from 1,3 13C glycerol or 2-13C glycerol as mentioned in 
Chapter 3, can simplify spectra and facilitate assignment,7 as the user knows which amino acids 
to expect in their spectra. These methods are particularly useful in 3D experiments where 
spectral overlap can be reduced using selective labeling schemes. For proteins however, 3D 
correlation experiments are needed to make unambiguous, site-specific assignments.  
Polarization transfer diagrams for each of the 3D experiments used in this study are 
presented in Figure 4.1. Using a common nitrogen frequency, the NCACX and NCOCX 
experiments provide connectivities between sequential amino acids in a protein sequence.9 The 
3D CANCO and CONCA experiments, first developed in the Rienstra laboratory, are 
particularly useful for chemical shift assignment purposes as further interresidue correlations can 
be identified.10 However, this experiment utilizes three cross polarization steps, and thus has low 
magnetization transfer efficiency due to loss of magnetization on each CP step. It is critical to 
prepare a high sensitivity sample in order to use these multidimensional experiments. 
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Figure 4.1. Schematic polarization transfer diagrams for multidimensional solid-state NMR 
experiments. (blue) In the NCACX experiment, polarization is transferred from the i residue N to the i 
residue CA and then to the surrounding atoms, (red) In the NCOCX experiment, polarization is 
transferred from the i residue N to the i-1 residue C’ and then to the i-1 surrounding atoms, (black) In the 
CANCO experiment, polarization is transferred from the i residue CA to the i residue N and then to i-1 
resiude C’, (purple) In the CONCA experiment, polarization is transferred from the i-1 residue C’ to the i 
residue N and then to the i resiude CA. 
 
 
 53 
To further alleviate spectral degeneracy, the 4D CANCOCX experiment can be used, and 
the feasibility of this experiment was presented for the 56-resiude protein GB1.11 For larger 
proteins, including sTF, pseudo-4D experiments, namely the CANcoCX and CONcaCX, can be 
used to take advantage of the CANCOCX magnetization transfer pathway. Table 4.1 summarizes 
commonly used solid-state NMR experiments for chemical shift assignment and compares them 
with their solution NMR counterparts.  
 
Table 4.1. Solution and solid-state NMR experiments for structure elucidation 
Experiment Solution NMR Solid-State NMR 
Spectrum 
Description 
2D correlation HSQC  (1H-15N) 
CC2D  
(13C-13C) 
Fingerprint 
spectrum, initial 
quality control 
spectrum 
HNCA NCACX 
Intraresidue 
correlations (short 
mixing time) 
HNCO NCOCX 
NHCACB CANCO 
3D correlation 
CBCANH CONCA 
Interresidue 
correlations 
 
HN(CO)CACB CAN(CO)CX 4D & Pseudo 4D 
correlation CBCA(CO)NH CON(CA)CX 
Interresidue 
correlations 
 
Both intraresidue (within the residue itself) and interresidue (between neighboring 
residues) correlations can be detected using multidimensional experiments with different 
polarization transfer pathways. Additionally, interresidue correlations can be found using 
different DARR mixing times; for example, 25 to 50 ms of DARR mixing yields intraresidue 
correlations, whereas 300 ms of DARR mixing yields exclusively interresidue correlations.8  
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Chemical shift analysis for biomolecules is a highly iterative processes involving the 
steps outlined below. Once all peaks in a spectrum have been picked, residue identification can 
occur. Each amino acid has a set of characteristic chemical shifts for each atom in the residue. 
Peaks are typed by the amino acid that they correspond to, they are given a unique identifier: 
often a high number that is not in the protein sequence. As the resides are site-specifically 
assigned from backbone walk analyses, this high numbering system is replaced with the number 
of the amino acid in the protein sequence. While the majority of CA residues can be found in the 
within 50-65 ppm, certain amino acids have outlier chemical shift values that make them more 
amenable to facile assignment. Amino acid typing of residues Glu, Val, Thr, Ser, Ala, Ile, Leu 
and Pro is typically performed first as these amino acids have distinctive chemical shifts. Also 
useful in amino acid typing and assignment is the identification of the side chain residues Glu 
CG and Asp CD. In spectra of longer mixing times, stronger peaks are intraresidue and weaker 
peaks can be interresidue correlations to the i or i ± 1 neighboring residues.  
Once NMR chemical shifts are assigned, they can be compared to existing X-ray 
crystallography data. ShiftX2 predicts chemical shift values for protein backbone and side chain 
atoms using PDB coordinates as an input.12 In this way, X-ray crystal structure data can be more 
readily compared with NMR data. The predicted chemical shifts for 1BOY13 and 2HFT14 are 
shown in Figure 4.2. A reverse approach is to use TALOS-N, which is an empirical program that 
uses NMR chemical shifts and an artificial neural network and database mining approach.15 
TALOS-N predicts the phi and psi torsion angles in a protein as well as the secondary structure 
elements of the protein in the form of alpha helix, beta sheet or loop using assigned NMR 
chemical shifts.15 Order parameters, which describe the relative flexibility or rigidity of each 
residue, are also reported by TALOS-N.15    
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Figure 4.2. Chemical shift predictions for 1BOY and 2HFT. Using ShiftX2, the predicted chemical 
shifts for the backbone atoms (C’, N, CA, and CB) for 1BOY (y-axis) and 2HFT (y-axis) are shown.  
 
The highest resolution X-ray crystal structure of sTF at 1.7 Å (PDB: 2HFT)14 is missing 
Gly87, Ser88, Ala89, and Gly90, all of which are in L6, as well as Ser161 and Ser162 in L11. In 
addition, there is a 6.3 Å difference in the backbone RMSD between 1BOY13 and 2HFT.14 X-ray 
reflections, in combination with NMR derived dihedral angle restraints, have been shown to 
improve the backbone precision in structure refinement calculations of membrane proteins.16 
This method can be applied to systems where low to medium resolution X-ray crystal structures 
are available. These studies use the structure determination program XPLOR-NIH17,18 in which 
X-ray crystal data provides the framework for the protein fold, and SSNMR restraints are used to 
define the local structure.16 Chemical shifts, J couplings, NOEs, dipolar couplings, chemical shift 
anisotropy, and paramagnetic relaxation enhancement data can all be incorporated as NMR 
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restraints in structure calculations with XPLOR-NIH.19 Some of the earliest applications of the 
combined approach of using NMR distance restraints and molecular dynamics were to the 
proteins crambin20 and al-purothionin.21 
 
4.4 Materials and Methods 
4.4.1 Sample preparation 
Two crystal forms of sTF were prepared using either polyethylene glycol (PEG) or 
ammonium sulfate as precipitants. sTF samples were precipitated with 5-20% PEG 3350 in 25 
mM sodium phosphate (pH 7.5) buffer or with ammonium sulfate (final concentration = ~1.8 M) 
in 100 mM HEPES (pH 7.5) buffer, 200 mM NaCl, 5 mM Cu-EDTA. Samples were packed into 
3.2 mm standard and limited speed rotors (Agilent Technologies, Santa Clara, CA, USA) for data 
acquisition.  
4.4.2 Solid-state NMR spectroscopy 
Spectra of ammonium sulfate-precipitated sTF were acquired on Varian NMR 
spectrometers (500 MHz VNMRS or 750 MHz VNMRS) equipped with 3.2 mm 1H-13C-15N 
Balun probes. The majority of spectra for purposes of PEG-precipitated sTF assignment were 
collected at 600 MHz (1H frequency) with a 3.2 mm 1H-13C-15N Balun probe. Spectra of PEG-
precipitated sTF spectra were acquired at 10 °C and used tangent ramped cross polarization22 
with ~80 kHz of SPINAL-64 decoupling.23 Ammonium sulfate-precipitated sTF spectra were 
acquired at 0 °C or -5 °C. Band-selective SPECIFIC CP24 was used for polarization transfer 
between 15N and 13C in the 3D 15N-13C-13C and 13C-15N-13C correlation experiments. Chemical 
shift assignments for precipitated sTF were made using 2D 13C-13C spectra, 2D NCA and NCO 
spectra, and 3D NCACX, NCOCX with DARR mixing,8 CANCO, CONCA, CANcoCX, and 
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CONcaCX spectra. Typical π/2 pulse widths were 2.5 µs for 1H and 13C, 5.25 ms for 15N. Spectra 
were processed with NMRPipe,25 with zero filling and varying amounts of Lorentzian-to-
Gaussian line broadening in each dimension. Referencing of chemical shifts was performed with 
adamantane (downfield peak at 40.48 ppm). Chemical shift assignments were made using 
Sparky.26  
4.4.3 Xplor structure calculations 
Initial structure calculations on sTF were performed using 1BOY (which contains 
coordinates for all sTF residues) as a starting structure, employing simulated annealing in Xplor-
NIH.17 2HFT X-ray reflections were used, as well as TALOS-N15 predicted backbone dihedral 
angles to refine the backbone RMSD of sTF. The top ten lowest energy structures were used for 
further analysis.  
 
4.5 Results & Discussion 
 
4.5.1 Solid-state NMR spectra for sTF assignment 
 
Solid-state NMR spectroscopy was utilized to investigate the structures of PEG and 
ammonium sulfate-precipitated sTF. A suite of intraresidue and interresidue multidimensional 
SSNMR experiments (Table 4.2) has been acquired in order to complete the chemical shift 
assignments of the backbone atoms of sTF. As the sTF samples do not have significant 
sensitivity to allow for 4D spectral acquisition in a realistic time frame, pseudo-4D experiments 
were acquired including the CANcoCX and CONcaCX to gain access to CB, C’ and side chain 
resonances for the ammonium sulfate preparation. 1,3 13C glycerol and 2-13C glycerol PEG 
samples were used heavily in chemical shift assignment of the PEG-precipitated form of sTF. 1,3 
glycerol and 2-glycerol samples of the ammonium sulfate-precipitated sample were prepared; 
 58 
however, the uniformly labeled samples provided sufficient sensitivity for chemical shift 
assignment purposes.       
 
Table 4.2. Spectra acquired for ammonium sulfate-precipitated sTF 
and PEG-precipitated sTF 
Sample Field Strength (MHz) Experiment 
Mixing Time 
(ms) 
Ammonium sulfate-precipitated sTF 
U-13C,15N 500, 750 CC2D 25, 100, 250, 300, 500 
U-13C,15N 750 CC2D SPC5, q40 
U-13C,15N 500, 750 NCA  
U-13C,15N 500, 740 NcaCX 100 
U-13C,15N 500, 750 NCACX 25, 50, 100 
U-13C,15N 500, 750 NCO 50 
U-13C,15N 500, 750 NCOCX 25, 100 
U-13C,15N 500 CANCO  
U-13C,15N 500 CANcoCX 25, 50 
U-13C,15N 750 CONCA  
U-13C,15N 750 CONcaCX 100 
PEG-precipitated sTF 
U-13C,15N 600, 750 CC2D 25,50 
U-13C,15N 600 TEDOR n=16 
U-13C,15N 600 NcaCX 50 
U-13C,15N 600 NCACX 50 
U-13C,15N 600 NcoCX 50 
U-13C,15N 600 NCOCX 50 
U-13C,15N 600 CANCO  
2-13C glycerol 600 NCACX 300 
2-13C glycerol 600 NCOCX 300 
2-13C glycerol 600 CANCO  
1,3-13C glycerol 600 NCOCX 300 
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4.5.2 Chemical shift assignment of sTF 
The majority of the backbone atoms (N, Cα, Cβ, C’) of PEG-precipitated and ammonium 
sulfate-precipitated sTF have been assigned sequentially and confirmed uniquely on the basis of 
solid-state NMR data sets. All of the 26 Thr residues have been assigned as well most of the Ser 
residues, including those in L11. The SPC527,28 13C-13C 2D spectrum shown in Figure 4.3, is 
particularly useful as one-bond correlations are positive peaks (shown in blue) and two-bond 
correlations are negative (shown in red). In this way, atoms that are not directly bonded to the 
CA resonance can be observed and the sign of the peak indicates how close the atom is to its 
correlated CA. For example, each of the off-diagonal Thr and Ser resonances are blue, indicating 
that they are one bond away from their corresponding diagonal CA resonances. Further, using 
longer DARR8 mixing times yields spectra with additional interresidue correlations. These 
spectra, shown in Figure 4.4, are particularly useful in confirming connectivities and determining 
inter-atom distance restraints.  
Figure 4.3. 13C-13C SPC527,28 correlation spectrum of ammonium sulfate-precipitated sTF. (A) The 
aliphatic region of the 13C-13C correlation spectrum is shown with one-bond correlations in blue and two-
bond correlations in red. (B) Close-up of the Ser/Thr CA-CB region.  
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Figure 4.4. 13C-13C correlation spectra of ammonium sulfate-precipitated sTF with DARR8 mixing. 
Spectra acquired with 100 ms, 300 ms, and 500 ms of DARR mixing at 750 MHz (1H frequency), under 
otherwise identical conditions, reveal additional off-diagonal correlations at higher mixing times.   
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Using the NCACX (red), NCOCX (blue) and CANCO (black), a sequential backbone 
walk is performed for residues Val64, Lys65, Asp66, and Val67 (Figure 4.5), with the residues 
shown located in turns in the 1BOY crystal structure. For example, at a 15N frequency of 110.8 
ppm, the CA, CB, and C’ of Asp66 can be observed in the NCACX spectrum (red) which yields 
intraresidue correlations at 25 ms of DARR mixing. The Asp66 CA is found in the CANCO 
(black) by searching at roughly the same 15N frequency (110.6 ppm). As each experiment was 
acquired under different experimental conditions and occasionally with different samples, 
variations in 15N frequency of ~0.2-0.3 ppm are common. The CA and N in the CANCO 
experiment belong to the “i” residue, but the C’ belongs to the “i-1” residue, allowing for 
interresidue correlations to be established (for Lys65 in this case). Using the same initial Asp66 
15N frequency in the NCOCX experiment (blue), the C’ of Lys65 leads us to its own CA and CB 
resonances. If there were only one Lys-Asp pair in the protein sequence, these residues would 
then be site-specifically assigned. In this way, sequential connectivities can be made and pieced 
together to complete site-specific assignments along the entirety of the protein backbone.  
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Figure 4.5. Sequential backbone walk for PEG-precipitated sTF with 25 ms DARR mixing. Spectra 
shown are the NCACX (red), NCOCX (blue), and CANCO (black) acquired at 750 MHz (1H frequency). 
 
 
The gain in sensitivity from the ammonium sulfate sTF samples enabled the acquisition 
of the CANCO, CANcoCX, CONCA, and CONcaCX spectra which provide sequential 
interresidue connectivity information to further assign atoms in the protein backbone. Figure 4.6 
shows a backbone walk for ammonium sulfate-precipitated sTF with 100 ms of DARR mixing 
using the NCACX (red), NCOCX (blue), and CONcaCX (purple) experiments. Of particular 
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note, is the highly resolved Lys65 side chain atoms in the NCACX at 100 ms. Longer mixing 
times (upwards of 100 ms) allow for interresidue correlations to be seen and this is extremely 
useful in both identifying and verifying sequential amino acid connectivities; however, short 
mixing times provide necessary intraresidue correlations for initial chemical shift assignment. 
Notably in the 100 ms mixing data, both Val residues are missing their C’ atoms in the 
CONcaCX. 
 
Figure 4.6. Sequential backbone walk for ammonium sulfate-precipitated sTF with 100 ms DARR 
mixing. Spectra shown are the NCACX (red), NCOCX (blue), and CONcaCX (purple) acquired at 750 
MHz (1H frequency). 
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Figure 4.7 illustrates the challenge of chemical shift assignment in large proteins where 
there is significant spectral degeneracy. In the first nitrogen plane of 132 ppm (A), the spin 
system of Gln114 (CA, CB, and CG resonances) is clearly seen without any ambiguity. In B, the 
nitrogen plane of 110.5 ppm also looks relatively straightforward, with peaks of similar 
intensities at a 13C chemical shift of ~54.5 ppm in the second dimension. Upon closer inspection, 
there are two overlapping resonances at the CA position of ~55 ppm, namely the Asp66 CA-CA 
and Lys159 CA-CA correlations. Due to the medium range mixing time of this experiment of 
100 ms, neighboring atoms to Asp66 and Lys159 could also be seen. In fact, correlations to the 
CA, CB, and CD of Lys65 as well as the CA of Ser160 are seen in this plane. While the longer 
mixing time yields a greater number of resonances, often the lower intensity peaks represent 
correlations to neighboring atoms and are useful in making new connectivities as well as 
confirming existing ones. Plane C reveals the complexity that can be seen in NMR spectra 
resulting from resonance overlap. Three CA-CA correlations are overlapping at a 13C chemical 
shift of ~58 ppm and each of the overlapped peaks belong to a different Ser residue, namely 
Ser85, Ser97 or Ser160. Whereas plane B contained two types of amino acid residues, D and K, 
having very different characteristic chemical shifts, plane C consists of three overlapping 
residues of the same amino acid type. Again, the longer mixing time serves to confirm 
neighboring connectivities including Thr86 CB and CG2, Lys159 CE, Pro98 CD, and Glu84 CA. 
but additional 3D correlation experiments such as the NCOCX and CONcaCX were used to 
assign each of the three Ser residues. In all, 90% of backbone (C’, N, CA, CB) chemical shifts 
were assigned in the PEG-precipitated form of sTF, and 85% of backbone chemical shifts were 
assigned in the ammonium sulfate-precipitated form. Due to the increase in sensitivity of the 
ammonium sulfate-precipitated sample, the majority of side chain resonances have been 
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assigned. Most striking are chemical shift assignments for the CG atoms, which were not 
previously reported in the solution NMR assignments; 57% of the expected CG atoms were 
assigned in the PEG-precipitated form and 92% were assigned in the ammonium sulfate-
precipitated form. Additionally, 52% and 83% of the CD atoms were assigned, as well as 47% 
and 59% of the CE atoms, in the PEG and ammonium sulfate-precipitated forms, respectively. 
 
Figure 4.7. 15N-13CA-13CX 3D correlation spectrum with 100 ms DARR mixing. (A) 15N chemical 
shift of 132 ppm showing one spin system, (B) 15N chemical shift of 110.5 ppm with two overlapping 
spin systems, (C) 15N chemical shift of 118.2 ppm with three overlapping spin systems.  
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4.5.3 Secondary structure 
CA and CB chemical shifts are highly sensitive to changes in secondary structure and 
perturbations can offer insight into different secondary structure among the various sTF 
preparations. For N and C’ chemical shifts, it is common to observe greater variations in these 
values between preparations, as the differences are attributable to electrostatic effects and crystal 
packing interactions. A comparison of the published solution NMR chemical shifts versus the 
ammonium sulfate-precipitated solid-state chemical shifts is presented in Figure 4.8. The 
majority of the CA chemical shifts are highly similar between solution and solid-state NMR, but 
the C’ and N chemical shifts vary significantly. In particular, residues Cys186 and Thr101 have 
chemical shift perturbations for both C’ and N. Between the two solid-state precipitated forms, 
there is a high degree of similarity between the CA and CB chemical shifts, with variation 
among the C’ and N chemical shifts. It is important to note that the ammonium-sulfate 
precipitation contains a high concentration of ammonium sulfate ~1.8 M as well as 200 mM 
NaCl, which is four times the amount in the PEG-precipitated sample. Due to the differences in 
sample preparations, perturbations to the chemical shifts are likely to be observed, especially for 
the CA and CB shifts, among the two crystal forms of sTF.  
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Figure 4.8. Chemical shift differences for sTF in solution and in the solid-state. Solution chemical 
shifts for sTF (y-axis) are plotted against the ammonium sulfate-precipitated sTF in the solid-state (x-
axis). Chemical shifts are shown for the resolved C’, N, and CA atoms for each residue in sTF. Outlier 
chemical shifts are labeled.  
 
The secondary structure of sTF from the existing X-ray crystal data13 indicated that 45% 
of the structure is beta sheet (19 strands, 100 residues) and 7% is alpha helical (4 helices; 16 
residues) using the DSSP secondary structure algorithm.29 Secondary structure elements of 
nanocrystalline sTF were predicted using the backbone (N, CA, CB, C’) SSNMR chemical shifts 
in TALOS-N,15 a backbone dihedral angle empirical prediction program. Figure 4.9 shows the 
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order parameter values predicted for both crystal forms of sTF. Order parameters below 0.5 
indicate a dynamic, less-ordered region of the protein. sTF is predicted to be primarily β-sheet in 
secondary structure from TALOS-N, which is consistent with the presence of two fibronectin 
type III domains. The X-ray crystal structures 2HFT14 and 1TFH14 are missing electron density 
for residues Gly87-Gly90 and Ser161-Ser162, and Glu84-Ser88, respectively; however backbone 
atoms for Ser85-Ala89 and Ser161-Ser162 have been assigned using SSNMR. As seen in Figure 
4.9, these regions are more dynamic than the rigid β-sheets, likely accounting for the disorder 
observed in the crystal structures. Additionally, the PEG-precipitated form has a more dynamic 
L6 than the ammoniuum sulfate precipitated form, which could be attributed to the differences in 
crystallization buffers, particularly the salt concentration mentioned earlier. In this way, it is 
difficult to make a direct comparison between the order parameters shown for both forms in 
Figure 4.9. The loop regions in the ammonium sulfate precipitated sample could be immobilized 
due to crystal contacts and would have decreased dynamics as predicted by TALOS-N.15 
 
Figure 4.9. TALOS-N predicted order parameters for sTF crystal forms. PEG-precipitated sTF order 
parameters are shown in black and ammonium sulfate-precipitated sTF order parameters are shown in 
orange.  
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4.5.4 Structural refinement of sTF 
The two highest resolution sTF crystal structures (1BOY and 2HFT)13,14 have a difference 
in backbone RMSD of 6.3 Å, indicating highly unique backbone conformations. Higman et al. 
have demonstrated that SSNMR chemical shift assignments can complement X-ray 
crystallography data for loops of varying conformation in bacteriorhodopsin, a 26 kDa 
membrane protein, in its native lipid environment.30 Using the protocol in Tang et al., Xplor-NIH 
was used to investigate the conformations of the loops in sTF using the X-ray crystal structures 
as starting points (26).16 1BOY and 2HFT were compared using the structural alignment 
program, Protein3DFit.31 Using this alignment algorithm, the structural differences between the 
two crystal structures were identified, and the regions with RMSD differences greater than 0.7 Å 
were removed from the reflection data sets. Using Xplor-NIH, 100 structures were generated for 
each calculation, and the ten lowest energy structures were selected for RMSD analysis.  
The top ten lowest energy NMR-refined structures have a backbone RMSD of 0.65 Å 
(Figure 4.10). In particular, the backbone RMSD for the loop between residues Glu84 to Gly90 
and Lys159 to Gly164 is 1.40 Å and 1.14 Å, respectively. When the lowest energy NMR-derived 
structure was compared with 1BOY, the backbone RMSD was 1.99 Å, with loops Glu84 to 
Gly90 and Lys159 to Gly164 having RMSD values of 1.06 Å and 2.24 Å, respectively. 
Interestingly, the lowest energy NMR structure matched very well with L6 of 1BOY, but L11 
was not refined below the threshold of resolution of the 1BOY structure alone.  
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Figure 4.10. XPLOR-NIH structure calculations on sTF. (A) The top ten lowest energy structures of 
sTF as determined by simulated annealing. (B) The lowest energy structure (gray) overlaid with 
1BOY(blue).  
 
 
 
4.6 Conclusions 
Solid-state NMR chemical shift assignments have been made for the majority of the 
backbone atoms in PEG and ammonium sulfate-precipitated sTF. The predicted secondary 
structure elements are comparable to the X-ray crystal structure data; however, not all residues in 
the loop regions could be uniquely baseline resolved. Examining perturbations of the chemical 
shifts will reveal residues that are involved in membrane-binding, as well as provide structural 
insights about the different conformations of TF in its various forms. The proposed experiments 
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will aid in the ultimate goal of solving the structure of sTF utilizing NMR spectroscopy in order 
to further understand the interactions between this vital blood coagulation protein and its 
associated phospholipid membranes.  
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CHAPTER 5  
Investigating the Dynamics of Human Soluble Tissue Factor:  
An Integrated Approach 
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5.2 Abstract  
Probing protein dynamics can offer unique insight into the functionality of an enzyme 
complex. NMR spectroscopy, both solution and solid-state, can provide motional information for 
timescales that are inaccessible to other biophysical techniques. Here, an integrative approach is 
employed to examine dynamics of human soluble tissue factor (sTF) using solution and solid-
state NMR experiments, as well as molecular dynamics simulations. Order parameters derived 
from solution relaxation rates, solid-state dipolar couplings, and molecular dynamics trajectories 
will be presented. These methods, in combination with existing structural studies of sTF by other 
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methods, will provide further insight into sTF dynamics by clarifying the roles of the loop 
residues and help to elucidate the mechanism of TF/fVIIa complex formation.  
5.3 Introduction 
Protein motions are responsible for a wide array of processes such as ligand binding, 
catalysis, and signaling.1,2 In particular, protein motions can occur over broad timescales (from 
picoseconds to seconds) and are often difficult to fully characterize with a singular biophysical 
technique. NMR spectroscopy is poised to access the dynamics of proteins over many timescales 
(Figure 5.1), at site-specific resolution, in order to more fully understand systems of biological 
interest, and can provide complementary information to existing structural data. Solution and 
solid-state NMR have been used to obtain relaxation data, scalar couplings, and dipolar 
couplings; these experiments, along with selective isotopic labeling schemes, can provide insight 
into protein function and mechanism. Here, the dynamics of proteins implicated in blood 
coagulation will be investigated in an integrative approach utilizing solution NMR, solid-state 
NMR, and molecular dynamics (MD). A similar integrated approach has been used to 
characterize the dynamics of the 62-residue alpha-spectrin SH3 domain3 using solution 
relaxation data and solid-state dipolar couplings. Here, this approach will be applied to a 219-
residue protein implicated in blood coagulation. 
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Figure 5.1. Protein motions accessible on the NMR timescale. Adapted from Palmer et al.2 
 
The blood coagulation cascade is triggered upon exposure of the integral membrane 
protein, tissue factor (TF), to the plasma. The activated plasma serine protease, factor VII (fVIIa) 
then binds to TF, and this complex activates fX. The series of reactions culminates in the 
formation on fibrin filaments, which stabilize the platelet plug and form a blood clot. The ~26 
kDa isolated soluble extracellular domain (sTF) has been structurally characterized using X-ray 
crystallography; however the highest resolution X-ray crystal structures are missing electron 
density in the functional loop regions of sTF as examined by the B factors for several sTF crystal 
structures.4,5 Higher B factors indicate higher fluctuations of the atoms, are often seen in 
dynamic loop regions of proteins. Loop 6 (L6) involves residues (Pro79-Pro92) that are 
responsible for the allosteric activation of fVIIa, where Loop 11 (L11) residues (Trp158-Lys166) 
modulate TF-membrane binding. As sTF is a highly structured protein consisting primarily of 
beta-sheets, dynamics are largely limited to these loop regions of the protein. In addition, 
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mutagenesis studies have shown that TF undergoes conformational changes upon forming the 
TF/fVIIa complex.6-9 In one study, twenty surface exposed residues identified through MD 
simulations10 were subjected to alanine mutagenesis.9 In sTF alone, mutated residues in Loop 11 
(from Lys159-Gly164) that interact with phospholipids, in particular phosphatidylserine 
headgroups were shown to have a significant decrease in activity.9 Time-resolved fluorescence 
has also been utilized to investigate sTF and has revealed substantial flexibility in L6,11 which 
experiences a decrease in conformational flexibility upon binding to fVIIa. All of these studies 
indicate that TF undergoes conformational changes in order to accommodate binding to its 
substrate, fVIIa. NMR can provide highly complementary information to X-ray crystallography, 
fluorescence, and mutagenesis studies, as the dynamic L6 and L11 residues are observed in both 
solution and solid-state NMR spectra. 
5.3.1 Relaxation measurements 
Solution NMR relaxation R1 and R2 experiments can be used to access protein motions 
on fast timescales, on the order of ps to ns.12-14 The inverse of the time constants T1 and T2 are 
R1, the longitudinal relaxation rate and R2, the transverse relaxation rate, respectively. Peak 
linewidths directly correlate to dynamics in solution and can also be used to describe protein 
motions in the form of chemical exchange, with broader linewidths indicating more rapid 
relaxation. Carr-Purcell-Meiboom-Gill (CPMG)14 relaxation dispersion and R1ρ15 experiments 
yield dynamics information in the range of ~300 s-1 to 50,000 s-1, and are often employed when 
interrogating the rate of exchange in of a molecule with two distinct conformations. These 
methods are commonly used to obtain dynamics information of side chain and loop residues. 
Solution dynamics measurements have been obtained for proteins such as ubiquitin16,17, GB317, 
and RNase A.18-20 
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5.3.2 Dipolar couplings 
Site-specific dynamics can further be interrogated utilizing dipolar couplings between 
spins. In this, way ps to ns dynamics can be indirectly probed. Mansfield, Rhim, Elleman, and 
Vaughan (MREV) has been used to reduce homonucelar dipolar line broadening.21 T-MREV 
(transverse-Mansfield, Rhim, Elleman, and Vaughan) is used to restore 1H-15N and 1H-13CA 
dipolar couplings using only the transverse component of the effective field.22 The use of T-
MREV was demonstrated on n-acetyl valine using a 3D 1H-15N-13C-1H gamma encoded T-
MREV experiment to unambiguously identify each 15N-13C correlation and obtain torsion angle 
restraints for each residue.23 Further, 1H-15N dipolar couplings of the beta immunoglobulin 
binding domain of Protein G (GB1) have been determined as well as bond angles for use as 
restraints in high resolution structure calculations.24 Chevelkov et al. have also used solid-state 
dipolar couplings were used to probe dynamics on the sub-ns time scale, using perdeuterated 
samples with 10% back-exchanged protons.3 Their work identified ns to µs dynamics in the loop 
regions and termini of the alpha-spectrin SH3 domain.3 
5.3.3 Order parameters 
One way to characterize protein backbone and side chain dynamics is to determine the 
order parameter (S2)26 either experimentally or computationally. Order parameters report on how 
dynamic or rigid a region or atom in a protein is, and is often self-consistently normalized; 
however, care must be taken when comparing order parameters from various methods to one 
another as they are often derived differently. Typically, in solution NMR, backbone amide sites 
have order parameters above 0.8, where the loop, turns, and termini can have order parameters in 
the range of approximately 0.5 to 0.8.25 In Chevelkov et al., order parameters from conventional 
solution relaxation experiments were compared to 1H-15N residual dipolar couplings (RDC) and 
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solid-state dipolar couplings.3 The RDC values were scaled in relation to the solution relaxation 
based order parameters so that they could be more easily compared. Order parameters from this 
study ranged from 0.8 to 0.95 with the average being ~0.91 and one outlier residue having an 
order parameter of 0.62.3 
Additionally, instead of predicting order parameters with TALOS-N27 from chemical 
shifts as was described in Ch 4, order parameters can be experimentally measured using T-
MREV experiments. Order parameters less than 0.5 are considered highly mobile and are 
normalized to 1 based on the rigid lattice limit inherent to the T-MREV experiment. For the T-
MREV order parameter, S, the dipolar coupling is extracted from experimental data and order 
parameters are normalized based on the rigid lattice limit.  
5.3.4 Molecular dynamics (MD) 
MD simulations are commonly used to investigate protein dynamics and are particularly 
helpful in visualizing motions over a large range of timescales..28 Enzyme kinetics29-31 and 
protein folding and misfolding32,33 are all events that are easily accessed by MD. Motions of 
individual atoms can also be probed very specifically, enabling the facile detection of more 
subtle, smaller-scale dynamics than would be achievable by some experimental techniques. 
Large biomolecular systems can be studied using MD, for example the F1 ATPase34,35 and the 
signaling Src proteins.36  
Here, we investigate sTF focusing on dynamic loops using an integrated approach 
through the complementary techniques of X-ray crystallography, solution and solid-state NMR, 
and MD. In combination with chemical shift derived structural information, dynamics 
information provides a deeper understanding of function of the TF/fVIIa complex as a whole. 
Ultimately, gaining a greater understanding of blood coagulation factor protein structure at an 
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atomic scale could lead to therapeutic improvements and understanding sTF dynamics will 
provide a benchmark for identifying residues of interest that may be affected in TF/fVIIa 
complex formation.  
 
5.4 Materials & Methods 
5.4.1 Protein expression & purification 
sTF was expressed and purified as previously described in Chapter 3. Cells containing the 
plasmid pJH677 with the sTF-His construct were grown on LB agar plates containing 50 µg/mL 
kanamycin. A modified Studier media was used to grow cells at natural abundance before 
growing cells in the desired isotopically enriched media. sTF expression was induced with 100 
µM IPTG overnight at 37 °C after which cells were harvested via centrifugation. sTF was 
released from cells via osmotic shock and impurities were removed with Q-Sepharose® Fast 
Flow anion exchange resin (Sigma-Aldrich, St. Louis, MO, USA). sTF was further purified using 
Ni2+ affinity chromatography, concentrated using 10 kDa molecular weight cut-off centrifugal 
filters, and dialyzed to remove excess imidazole. Samples for use in solid-state NMR were 
precipitated using 1.8 M ammonium sulfate and 5 mM Cu-EDTA.  
5.4.2 NMR spectroscopy 
Solution R1 and R2 relaxation experiments were performed at the University of Illinois at 
Chicago on a 900 MHz (1H frequency) Bruker spectrometer (Billerica, MA, USA) equipped with 
a standard triple resonance 5 mm inverse TXI probe. Solid-state NMR spectra were acquired on 
Agilent/Varian 750 MHz (1H frequency) using 3.2 mm 1H-13C-15N Balun probes (Agilent 
Technologies, Santa Clara, CA, USA).  
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T-MREV experiments were performed on U-13C,15N sTF samples to interrogate the 
dynamics of site-resolved backbone amide protons and protons directly bonded to CA atoms. 1H-
15N T-MREV spectra were collected for 35 hours at -5 °C with a MAS rate of 8 kHz and a 
bigN_tmrev of 4. 50 Hz of line broadening were applied to each dimension. 1H-13CA T-MREV 
spectra were collected for 75 hours at -5 °C with a MAS rate of 8 kHz and a bigN_tmrev of 4. 50 
Hz of line broadening were applied to the F1 and F2 dimensions. Peaks were detected in 
NMRDraw37 and the F3 dimension was fit by gamma6, a FORTRAN 77 fitting algorithm.23  
5.4.3 Molecular dynamics simulations 
The initial coordinates for sTF were taken from entry 1BOY38 in the RCSB Protein Data 
Bank. Crystallized waters were retained in the model generated. Hydrogen atoms, a C-terminal 
carboxylate capping group, and an N-terminal ammonium capping group were added to the 
structure using VMD.39 The protein was then solvated in 29,652 waters were used to solvate the 
protein. Ions were added to the system (88 Na+ and 84 Cl-) in order to ionize the system to 150 
mM NaCl and neutralize the system. The system’s final dimensions were 100 x 80 x 121 Å3 with 
a total atom count of 92,445 atoms. The system was energy minimized and equilibrated in an 
NPT ensemble for 5 ns. Following this, a 100 ns production run was performed. All simulations 
were performed using NAMD240 together with the CHARMM36 set of force field 
parameters41,42 and the TIP3P water model.43 Constant pressure was maintained at 1.0 atm using 
the Nosè-Hoover Langevin piston method44,45 and constant temperature was maintained at 310 K 
using a Langevin damping coefficient of 1 ps-1.  Non-bonded interactions were cut off after 12 Å 
with a smoothing function applied after 10 Å. Long-range electrostatics were calculated using 
the particle mesh Ewald (PME) method46 utilizing a grid density greater than 1 Å.3 A timestep of 
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2 fs was used with bonded and non-bonded terms calculated every timestep and PME 
electrostatics calculated every other timestep. 
 
5.5 Results & Discussion 
5.5.1 sTF dynamics in solution 
NMR experiments meauring R1 and R2 relaxation rates were used to probe the fast 
timescale dynamics (in the ps to ns range) of sTF in solution. When R1 is mapped onto the sTF 
crystal structure (PDB ID: 1BOY), several residues of interest exhibit increased R1 relaxation 
rates (Figure 5.2 A). In particular, L6 shows increased motion and R1 relaxation rates on the 
order of 0.86 s-1 to 1.14 s-1, with the structured regions of the protein having R1 relaxation rates 
of ~0.3 s-1 (Figure 5.2 B). Fluorescence experiments using sTF also showed increased dynamics 
in L6.11 Additionally, several “hot spots” of motion are seen in the hinge region which connects 
the two fibronectin type III domains in sTF and is between a short beta sheet and helix in the X-
ray crystal structures. Residue Thr101 and residue Leu59 yield R1 rates of 1.15 s-1 and 0.96 s-1, 
respectively. Suprisingly, L11 does not display heightened dynamics in the relaxation data, 
except for Lys165. Higher R1/R2 ratios indicates potential conformational exchange. In Figure 
5.3, residues 214-228 of the His-tagged sTF construct act as an internal control since the R1/R2 
ratio is the largest, indicating a highly dynamic region of the protein, as would be expected for 
the unstructured termini.  
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Figure 5.2. R1 and R2 relxation rates for sTF. (A) R1 and R2 relaxation rates for sTF are mapped onto 
the 1BOY crystal structure. (B) Relaxation rate values are plotted for corresponding sTF residues with R1 
in blue and R2 in red.  
 
 
5.5.2 Solid-state NMR derived order parameters 
T-MREV experiments were used on ammonium sulfate-precipitated sTF samples to 
measure dipolar couplings and order parameters from fitting the extracted line shapes. All of the 
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1H-15N line shapes fit for sTF are shown in the 15N-13CA correlation spectrum in Figure 5.3. Both 
1H-15N and 1H-13CA dipolar coupling data sets were collected and normalized to the rigid lattice 
limit of 0.485 for n=4 in the T-MREV experiment.11 1H-15N line shapes for L6 and L11 are 
shown in Figure 5.4.  
 
 
Figure 5.3. 15N-13CA correlation spectrum labeled by T-MREV fits. Residues with completed 1H-15N 
T-MREV fits are labeled on the 15N-13CA 2D correlation spectrum of U-13C,15N sTF. 
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Figure 5.4. 1H-15N T-MREV dipolar line shapes for sTF loops. (A) 1H-15N line shapes for L6 are 
shown with experimental data in black and fits in red. (B) 1H-15N line shapes for L11 residues with 
experimental data in black and fits in red. 
 
 
Sharp line shapes with distinct sidebands indicate rigidity, while broader line shapes indicate a 
dynamic residue. In Figure 5.4 B, Trp158 is dynamic, with its very broad fitted sidebands. 
Several resonances were not baseline resolved and are overlapped including Ser85 and Ser160, 
Thr55 and Ser161. 1H-13CA line shapes for L6 and L11 are shown in Figure 5.5. Both sets of line 
shapes in Figures 5.4 and 5.5, reveal different order parameters for each residue, for example 
Trp158, whose N atom is very dynamic, has a more rigid CA.  
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Figure 5.5. 1H-13CA T-MREV dipolar line shapes for sTF loops. (A) 1H-13CA line shapes for L6 are 
shown with experimental data in black and fits in red. (B) 1H-13CA line shapes for L11 residues with 
experimental data in black and fits in red. 
 
Line shapes for selected non-loop residues and their associated time domain data fits are 
shown in Figures 5.6 and 5.7. Residues located in beta-sheets, according to 1BOY47, are Val36, 
Ile113, Ala168, and Phe175. Thr197 is found in a bend and Thr203 is in the unstructured termini.  
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Figure 5.6. 1H-15N T-MREV dipolar line shapes for selected sTF residues. 1H-15N line shapes and 
time domain data for residues in beta-sheets are shown with experimental data in black and fits in red.  
 
 
Figure 5.7. 1H-13CA T-MREV dipolar line shapes for selected sTF residues. 1H-13CA line shapes and 
time domain data for residues in beta-sheets are shown with experimental data in black and fits in red.  
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In general, the order parameters determined from the solid-state T-MREV experiments 
(Table 5.1) are higher overall than those calculated from solution NMR, most likely due to 
immobilization of the loop residues from crystal contacts. In Chevelkov et al., the motions were 
reserved to the loop regions of the SH3 domain.3 Additionally, the µs to ms and ns to µs 
backbone motions may be confined to the loops regions of sTF and may be more easily seen in 
3D 1H-15N-13CX T-MREV experiments aimed at accessing the dynamics of side chain residues.  
 
Table 5.1. T-MREV derived order parameters for selected L6 and L11 residues 
Residue 1H-15N 1H-13CA 
Loop 6 (L6) S S 
Ala80 0.91 0.94 
Asn82 0.81 0.94 
Val83 1 0.99 
Glu84 0.87 0.93 
Ser85* 0.91 0.97 
Thr86 0.95 0.93 
Ala89 1 0.93 
Loop 11 (L11)   
Trp158 0.73 0.97 
Lys159 0.80 0.96 
Ser160* 0.91 0.97 
Ser161 0.82 0.94 
Ser162 1 0.99 
Lys165 0.86 0.90 
Lys166 1 1 
Thr167 0.88 1 
      *Residues are overlapped in the 15N-13CA spectrum. 
      All residues are normalized to the rigid lattice limit. 
 
5.5.3 Analysis of simulation trajectory 
In order to make a direct comparison between MD simulation and experimental data, we 
calculated multiple readily measurable experimental quantities, such as protein order parameters, 
R1 relaxation parameters, and dipolar couplings. Calculation of NMR observables from MD 
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simulation trajectories has been detailed extensively elsewhere.42,48,49 Multiple observables can 
be extracted from simple transformation of the autocorrelation function. The autocorrelation 
function, C(t) is measured as the second-order Legendre polynomial of the cosine of the angle 
between the backbone amide at τ and a later time, τ+t (Equation 5.1): 
Ci(t)=⟨P2[µi(τ)⋅µi(τ+t)]⟩=⟨(3cos2θi-1)/2⟩ 
where θi is the angle between the N-H vector of the ith residue at time τ and τ+t. The 
autocorrelation function can also be defined in terms of the generalized squared order parameter, 
S2 (Equation 5.2): 
C(t)=S2+(1-S2)e-t/ζ 
where ζ is the time constant for decay of internal motions of the protein. Therefore, the order 
parameters can be extracted as the long-time (plateau) value of C(t) (i.e., S2=C(∞)). Additionally, 
the R1 relaxation parameter can be calculated from the backbone amide autocorrelation function. 
The R1 relaxation parameter is calculated as a sum of spectral densities, which, in turn, rely on 
the autocorrelation of the backbone amide. The form of R1 is given by Equation 5.3: 
R1=d2[J(ωH-ωN)+3J(ωN)+6J(ωH+ωN)]+c2J(ωN) 
where d is µ0hγNγH/8π2rNH3, c is a constant given by ∆σNωN, and J(ω) is the spectral density at 
frequency ω. Here, µ0 is the permeability of free space; h is Planck’s constant; γN and γH are the 
gyromagnetic ratios of 1H and 15N, respectively; and rNH is the length of the backbone amide 
bond, which was taken to be 1.02 Å in this study as this is the equilibrium length in the 
CHARMM36 force field. The spectral density at a particular frequency, ω, is given by the 
Fourier transform of C(t).  
The R1 relaxation parameter for each residue calculated from MD is shown in Figure 5.8, 
with the solution NMR R1 values. Overall, both of the methods yield R1 values that increase for 
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L6 and L11. The average baseline MD derived R1 values are slightly higher at ~0.4 s-1 than that 
of the solution NMR derived R1 values ~0.4 s-1. Also of note is the R1 calculated for Thr121 
from the MD simulation. Its R1 relaxation rate is 0.54 s-1, and this agrees well with the observed 
flexibity of Thr121 in free sTF from fluorescence.11 Thr121 is located in a turn between beta-
sheets that interact with the fVIIa Gla and EGF1 domains, but Thr121 does not have any direct 
contact with fVIIa and its motion is quenched when sTF is in complex with fVIIa.11  
 
 
Figure 5.8. A comparison of solution NMR and MD R1 values.  R1 relaxation rates from solution NMR 
(blue) and MD (black) are overlaid. 
 
 
The order parameters for sTF from TALOS-N using solution NMR and solid-state NMR, 
as well as from MD are shown in Figure 5.9. Here, the order parameters are compared across 
each method, with solution NMR matching most closely with the PEG-precipitated sTF sample 
and the MD result exhibiting the most dynamic L6. A similar result has been observed in Xue et. 
al, where MD tended to overestimate the B factors and order parameters of dynamic regions in 
ubiquitin from unrestrained simulations.50 Additionally, the ammonium sulfate-precipitated sTF 
sample is the least dynamic with the highest order parameters, potentially due to the high salt 
conditions of this crystal form, thereby immobilizing the otherwise dynamic regions.  
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Figure 5.9. A comparison of order parameters for sTF. (A) TALOS-N predicted order parameters for 
ammonium sulfate precipitated sTF (red) and PEG-precipitated sTF (blue). (B) Solution NMR TALOS+ 
predicted order parameters (black) and MD derived order parameters (gray). (C) Ammonium-sulfate 
(red), PEG-precipitated (blue), and solution NMR (black) predicted sTF order parameters. (D) 
Ammonium-sulfate (red), PEG-precipitated (blue), and MD derived (gray) sTF order parameters.  
 
 
A cross-correlation matrix was generated for the CA-CA correlations in sTF (Figure 
5.10). Off-diagonal complete positive correlations are observed for residues ~100 to ~60, 
potentially indicating motional interactions among the hinge region of sTF with L6. However, it 
appears that complete negative correlations are also seen throughout the matrix. L11 does not 
show any correlation in motion to other residues.   
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Figure 5.10. CA-CA correlation allosteric coupling network. Plotted is the cross-correlation matrix 
between the CA of each residue in sTF. These values were calculated over the entire 100 ns MD 
trajectory, with red representing complete positive correlation, blue representing complete negative 
correlation, and teal representing no correlation in motion between the CA of two residues. 
 
5.6 Conclusions 
 
The presented results utilizing both NMR and MD offer additional insight into the motion 
of sTF. These methods could be extended to the TF/fVIIa complex to directly probe local 
dyanmics of binding and could have an impact on our understanding of the mechanism of this 
biomedically relevant complex. This approach could also be used to probe side chain dynamics 
to gain a broader perspective of sTF motions. This is expected to be particularly useful in 
investigating the conformational dynamics of L6 and L11 in the TF/fVIIa complex and when 
bound to small molecule inhibitors. Increased mobility of side chain atoms could also be 
observed as side chains frequently exhibit motions on the timescales larger than 1 ns. Chevelkov 
et al. have demonstrated that the side chain motions do not significantly affect the structured 
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protein backbone.3 The side chain atoms of L6 and L11 would benefit from further study to 
elucidate their role in TF structure and function. 
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CHAPTER 6  
NMR Investigations Into Reconstituted Membrane-Bound TF  
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6.2 Introduction 
Membrane proteins are vital to a variety of cell processes such as cell signaling as 
receptors, cellular transport, and metabolism, among others.1 However, structural information of 
membrane proteins in their native phospholipid bilayers is difficult to access. As of April 2015, 
only ~6.5% of protein structures deposited in the PDB are of membrane proteins.2 This is due to 
the fact that membrane solubilization using detergents is very challenging and membrane protein 
expression and purification protocols typically have low yields, thereby limiting the application 
of X-ray crystallography and NMR spectroscopy to study membrane proteins.3 In particular, in 
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order to achieve sufficient sensitivity for NMR, milligram quantities of isotopically labeled 
sample are required, which can be limiting for membrane protein samples.4 
The lipid bilayer serves as an essential platform on which many blood coagulation 
reactions can occur. Phosphatidylcholine (PC) and sphingomyelin make up the bulk of the outer 
leaflet of the bilayer, while phosphatidylserine (PS) and phosphatidylethanolamine (PE) are 
sequestered to the inner leaflet. During coagulation, when vascular injury occurs, PS and PE are 
exposed to the outer leaflet and become accessible for clotting reactions.5 Several reactions in the 
clotting cascade require Ca2+ and negatively charged phospholipid headgroups, in the form of 
phosphatidylserine, including the formation of the TF/fVIIa complex.6 In particular, the gamma-
carboxyglutamate (Gla) domain of fVIIa interacts with the PS-containing bilayer. Tavoosi et al. 
showed that non-choline phospholipid headgroups synergize with PS to increase fX activation 
and preferential L-serine-specific binding to the fVIIa Gla domain occurs.7 Several residues of 
TF are known to interact with the lipid bilayer and PS headgroups.8,9 The single pass 
transmembrane helix not only anchors TF, but also promotes dimerization and oligomerization 
of TF.10 Additionally, there is a thioester linkage of a palmitate or stearate group to Cys245 in 
the cytoplasmic tail of TF.11  However, most of the binding energy of the TF/fVIIa complex is 
due to strong protein-protein interactions and not protein-lipid interactions.12  
One challenge of investigating membrane proteins is creating a “native-like” 
phospholipid environment that represents physiologic conditions. Nanodiscs have been widely 
used as a model membrane mimetic for biophysical studies.14-16 They are comprised of lipids and 
membrane scaffold protein (MSP), which hold the Nanodisc together and makes the Nanodisc 
soluble without the presence of detergents.17 An additional advantage of Nanodiscs is that they 
can be prepared in a variety of sizes, and they allow for specific local control over phospholipid 
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composition.17 Both sides of the Nanodisc are also accessible to membrane protein 
incorporation.17 Nanodiscs have been used in studies of OmpX by NMR spectroscopy,18 
Cytochrome P450 by Raman spectroscopy,19 Light harvesting complex II by electron 
microscopy and fluorescence,20 the GPCR rhodopsin by atomic force microscopy21 and electron 
microscopy,22 and coagulation factor binding by surface plasmon resonance.23  
While Nanodiscs provide a physiologically relevant state, a low protein to lipid ratio is 
not easily achievable in Nanodisc preparations, which is challenge for sensitivity in NMR 
experiments. Liposomes, vesicles consisting of a lamellar lipid bilayer, have been used in 
biomedical applications for drug delivery,24 and can be prepared as small unilamellar vesicles 
(SUVs) or large unilamellar vesicles (LUVs) by sonication or extrusion. Reconstituting mTF into 
liposomes could potentially allow for a higher protein to lipid ratio and would facilitate 
multidimensional solid-state NMR experiments. Ladizhansky and co-workers have reconstituted 
the integral membrane protein, proteorhodopsin, into liposomes and successfully performed 3D 
heteronuclear correlation experiments for chemical shift assignment purposes.25 The 
disadvantage to using liposomes is that it is often difficult to control both the size of the 
liposomes and the precise lipid stoichiometry of the bilayer.26 Many groups have used liposome 
preparations to study membrane proteins.25, 27-30 Pitard et al. incorporated bacteriorhodopsin into 
9:1 PC:PS liposomes with octylglucoside and Triton X-100 as the detergents.27 A similar method 
was used by Shi et al. where multidimensional solid-state NMR experiments were performed on 
proteorhodopsin reconstituted into 9:1 DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine): 
DMPA (1,2-dimyristoyl-sn-glycero-3-phosphate sodium salt) liposomes at a protein to lipid ratio 
of 0.5 to 1.25 NMR chemical shift assignments were made for ~67% of proteorhodopsin.25 A high 
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protein to lipid ratio of 1:1 was also achieved in experiments involving KcsA, where detergent 
dialysis was used to collect the protein-liposome precipitate.29  
Chapter 4 described methods for assigning solid-state NMR chemical shifts for proteins 
in the absence of lipids; in Chapter 6, this approach will similarly be applied to spectroscopic 
investigations of mTF. Since the extracellular domain of sTF is well characterized by NMR, any 
perturbations upon membrane binding will be seen in the chemical shifts, as they are a sensitive 
probe of the local chemical environment. Here, methods for isotopically labeling and purifying 
mTF are presented, as well as the associated solid-state NMR spectra for mTF reconstituted into 
Nanodiscs and liposomes.  
 
 
6.3 Materials & Methods 
 
6.3.1 U-13C,15N mTF expression 
 
A mTF glycerol stock was plated and grown overnight at 37 °C. Cells were inoculated 
into 25 mL natural abundance MDG (Modified Studier media, Chapter 3, Table 3.1) and grown 
for 4.5 hours at 37 °C at 300 rpm until an A600 of ~6-7 was reached. The preculture (1 mL) was 
added to four 2-L flasks containing 250 mL MDG and grown overnight at 37 °C at 300 rpm until 
an A600 between 5-7 was reached. The cell cultures were centrifuged for 15 minutes at 25  °C at 
6500 x g. Each pellet was resuspended in 250 mL MBG containing U-13C,15N BioExpress 
(Cambridge Isotope Laboratories, Tewksbury, MA, USA) and grown for 2 hours at 25 °C at 300 
rpm until an A600 of 6-7 was reached. Expression of mTF was induced with isopropyl β-D-1-
thiogalactopyranoside (IPTG) at a final concentration of 100 µM for 3.5 hours at 25 °C at 300 
rpm until an A600 of 6-7 was reached. Cells were harvested via centrifugation for 30 minutes at 
25 °C at 8500 x g. The cell pellets were stored at -80 °C prior to purification.  
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6.3.2 mTF purification 
Frozen cell pellets from 250 mL culture were rapidly thawed at 37 °C and resuspended in 
25 mL of 30 mM HEPES-NaOH (pH 7.5), 50 mM NaCl, 0.1% NaN3, and 2% n-octyl-β-D-
glucopyranoside (octylglucoside). The cells were shaken for 15 minutes at 25 °C at 200 rpm for 
15 minutes. Turbonuclease (Accelagen, San Diego, CA, USA; final concentration = 25 units/mL) 
was added and incubated for 15 minutes at 25 °C at 200 rpm. 10% Triton X-100 (final 
concentration = 0.5%) and 1 M CaCl2 (final concentration = 2 mM) were added, and the cells 
were put on ice for 30 minutes and then ultracentrifuged for 15 minutes at 4 C at 40,000 rpm. Q-
Sepharose® Fast Flow ion exchange media (Sigma-Aldrich, St. Louis, MO, USA) were 
equilibrated with five changes of 30 mM HEPES-NaOH (pH 7.5), 50 mM NaCl, 0.1% NaN3, and 
2 mM CaCl2. Equilibrated Q-Sepharose beads were added to the supernatant at 1 g beads per 10 
mL of supernatant and rotated for 40 minutes at 4 °C. The supernatant was collected by vacuum 
filtration, 0.02% NaN3 was added, and it was stored overnight at 4 °C.  
Ni2+ affinity chromatography for the His-tagged mTF construct or HPC4 antibody 
chromatography for the epitope-tagged mTF consruct was then used to further purify the 
supernatant. Prior to chromatography, the mTF supernatant was ultracentrifuged for 15 minutes 
at 4 °C at 40,000 rpm. For the case of the His-tagged mTF construct, two 5 mL HisTrap™ Fast 
Flow columns (GE Healthcare, Piscataway, NJ, USA) were equilibrated with five column 
volumes (50 mL) of binding buffer (25 mM sodium phosphate (pH 8) buffer, 2% octylglucoside, 
300 mM NaCl, 20 mM imidazole (pH 8)). NaCl (final concentration = 300 mM) and imidazole, 
pH 8 (final concentration = 20 mM) were added to the supernatant, which was subsequently 
filtered using a 0.45 µm membrane filter. The supernatant was loaded on the affinity columns 
and the columns were washed with 5-10 changes of binding buffer to remove any weakly bound 
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protein. mTF was eluted as a single sharp peak (monitored by A280) with 25 mM sodium 
phosphate (pH 8) buffer, 2% octylglucoside, 300 mM NaCl, 500 mM imidazole (pH 8). Pure 
mTF was concentrated using Centriprep™ centrifugal filter concentrators (EMD Millipore, 
Billerica, MA, USA) with a molecular weight cutoff of 30 kDa. The mTF was dialyzed against 
three changes of 25 mM sodium phosphate (pH 8) buffer, 50 mM NaCl, and 2% octylglucoside 
(1.33 L) to eliminate excess imidazole in the case of the His-tagged mTF construct. 
For the epitope-tagged mTF construct, HPC4 resin was equilibrated with five changes of 
1% octylglucoside, 30 mM HEPES-NaOH (pH 7.4), 100 mM NaCl, 2 mM CaCl2, and 0.1% 
NaN3. The mTF supernatant was incubated with the HPC4 resin for 30 minutes at 25 °C with 
mild rotation. The beads were collected by gravity flow and the column was washed with 1% 
octylglucoside, 30 mM HEPES-NaOH (pH 7.4), 1 mM NaCl, 1 mM CaCl2, and 0.1 % NaN3 
until a stable baseline was reached as monitored by A280. mTF was eluted as a single sharp peak 
(monitored by A280) with 1% octylglucoside, 30 mM HEPES-NaOH (pH 7.4), 100 mM NaCl, 5 
mM EDTA, and 0.1% NaN3. The HPC4 resin was stored in 30 mM HEPES-NaOH (pH 7.4), 50 
mM NaCl, and 0.1% NaN3. Yields of uniform 13C,15N mTF were ~20 mg per liter of media for 
the His-tagged mTF construct and ~8-10 mg protein per liter of media for the epitope-tagged 
mTF construct.  
6.3.3. Reconstitution of mTF 
After testing with natural abundance material, U-13C,15N mTF was reconstituted into 
Nanodiscs of varying phospholipid compositions as described in Shaw et al.23 Samples were 
lyophilized overnight and were then rehydrated at 2 to 1 sample mass to water. A yield of ~1.5 
mg mTF were packed into a 3.2 mm solid-state NMR rotor as analyzed by NMR. Liposomes for 
mTF incorporation were prepared as described in Smith et al.,30 using octylglucoside as the 
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detergent and BioBeads (Bio-Rad Laboratories, Hercules, CA, USA) for detergent removal. 
Briefly, 20 mg/mL of the desired phospholipids in chloroform were dried down under N2. The 
dried lipids were then flash frozen and lyophilized overnight. Prior to use, the lyophilized 
material was resuspended in the reconstitution buffer of 30 mM HEPES-NaOH (pH 7.5), 50 mM 
NaCl, and 0.1% NaN3. Isotopically labeled mTF was reconstituted into liposomes by adding the 
desired lipids (final concentration = 2 mg/mL), 212 mM octylglucoside (final concentration = 33 
mg/mL) and 5 mg/mL mTF (at varying concentrations to test different lipid to protein ratios 
from 30 to 1 up to 8666 to 1) together sequentially with the remaining volume being the 
reconstitution buffer. Samples were ultracentrifuged at 100,000 x rcf for 1 hour to pull down the 
protein-incorporated liposomes. The pellet is lyophilized, packed into a NMR rotor, and 
rehydrated at a ratio of 2 to 1 sample mass to water. Protein incorporation into the liposome 
pellet was determined using gel electrophoresis and A280 measurements of the supernatant. 
Additionally, clotting assays were performed on the pellets before packing into NMR rotors.  
6.3.4. Biophysical assays 
 
The prothrombin time clotting assay31 was used to measure the amount of time plasma 
would take to clot after the addition of mTF and CaCl2. Briefly, a coagulometer was pre-warmed 
to 37 °C and 50 uL of diluted relipidated mTF was loaded into the wells. Plasma and CaCl2 were 
prewarmed to 37 °C. After 60 seconds, 50 uL of plasma was added to the wells and was 
repeatedly added every 10 seconds to the wells. At 120 seconds, CaCl2 was added to initiate the 
clotting reaction, with clotting times reported in seconds.  
The cofactor activity of sTF was measured after relipidation using the fVIIa amidolytic 
assay as previously described.32 Briefly, 25 mM HEPES (pH 7.4), 100 mM NaCl, 5 mM CaCl2, 
0.1% bovine serum albumin, 5 nM fVIIa (Sekisui Diagnostics, Lexington, MA, USA) and 
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varying concentrations of sTF were added to each well of a 96-well plate. The reaction began 
upon addition of 1 mM Chromozym t-PA substrate (Roche Diagnostics, Indianapolis, IN, USA) 
to each well and the rate of substrate hydrolysis was quantified by measuring the change in A405 
for 20 minutes at 25 °C.  
6.3.5 NMR spectroscopy 
 
Solution NMR 1H-15N HSQC spectra of sTF were acquired at 750 MHz (1H frequency) 
using a Balun probe. Solid-state NMR spectra of mTF were collected at 500 MHz (1H frequency) 
and 750 MHz (1H frequency) over a range of temperatures and spinning rates to characterize T2 
relaxation, for samples in 3.2 mm and 1.6 mm NMR rotors. Spectra were processed with 
NMRPipe33 and analyzed in Sparky.34 
 
 
6.4 Results & Discussion 
 
6.4.1 Optimizing mTF yield 
sTF was expressed in BL21, making this strain a natural choice for trials of natural 
abundance mTF expressions; however, it was found that more mTF was expressed using C41 or 
C43 (Figure 5.1), which are commonly used in other membrane protein expressions.35 While the 
His-tagged construct produced a higher yield at first glance, the purified fractions of mTF 
became cloudy after sitting overnight at 4 °C; it is possible that misfolded mTF or mTF 
aggregates were precipitated out of solution. Upon ultracentrifugation, precipitation of mTF still 
occurred. This was not observed for the pure epitope-tagged mTF; thus, this construct was used 
in further NMR studies of mTF. 
 
Figure 6.1. Western Blot of mTF expression strains. 
BL21 C41 C43 
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Prior to investigation of mTF by solid-state NMR, we wanted to confirm if the 
reconstituted mTF samples in liposomes were active and unperturbed by the addition of 
detergent. The prothrombin time assay measured the extrinsic pathway of coagulation, 
specifically, the time it took for plasma to clot after the addition of mTF. The expression, 
purification, and reconstitution protocols yielded mTF activity that was comparable to a standard 
at a lipid to protein ratio of 8666 to 1 (Figure 6.2); thus, even with the lowest concentration of 
mTF (highest lipid to protein ratio), the sample activity is still intact. It is important to note that 
in the absence of fVIIa, clotting times for mTF by itself will be longer than the normal range of 
10-14 seconds. In Figure 6.2, the clotting times are ~150-200 seconds.  
To observe the effects of detergent on the structure of sTF, a 1H-15N HSQC solution 
NMR spectrum was acquired on a 100 µM sample of sTF in the presence of 2% octylglucoside. 
As can be seen in Figure 6.3, at this detergent concentration, there is no apparent perturbation to 
the chemical shifts of sTF, in comparison to the spectrum of sTF without detergent (Figure 6.3).  
 
 
Figure 6.2. Prothrombin time for relipidated mTF (black) in 100% POPC lipsomes and a mTF 
standard (gray). The lipid to protein ratios are 8666:1 (300 nM mTF) and 8000:1 (350 nM mTF). 
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Figure 6.3. 1H-15N HQSC correlation spectrum of sTF in the presence and absence of detergent. 15N 
labeled sTF in the presence of 2% octylglucoside (red) and 0% octylglucoside detergent (blue). The 
spectrum was acquired at 750 (1H frequency) at 35 °C. 
 
One challenge of the liposome reconstitution involved pelleting the liposome material. 
Despite ultracentrifugation after detergent removal with BioBeads, the pellet was semi-solid and 
was very difficult to transfer into the NMR rotor from the ultracentrifuge tube. Critical to the 
formation of robust pelleted liposomes is the complete removal of detergents.36 In addition to 
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BioBeads, methyl-β-cyclodextrin was used in increasing concentrations to facilitate detergent 
removal prior to ultracentrifugation. Using BioBeads and additions of 0.3 M methyl-β-
cyclodextrin, pellets formed after ultracentrifugation but were again difficult to transfer; 
although, flash-freezing the pellet did aid in transferring the material to the NMR rotor. In this 
manner, ~14 mg of material was transferred into a 3.2 mm NMR rotor, but the rotor only 
contained ~1 mg of mTF as analyzed by NMR.  
Previous mTF preparations in Nanodiscs have resulted in protein to lipid ratios that do 
not provide sufficient sensitivity to perform multidimensional SSNMR experiments. Yields of 
uniform 13C,15N labeled mTF are 10 mg of protein/L of media; however, only 1.5 mg and 0.5 mg 
of mTF were incorporated into 3.2 and 1.6 mm rotors, respectively. While Nanodiscs provide a 
physiologically relevant bilayer environment and allow for control over the local lipid 
composition, the use of liposomes may be more feasible for performing NMR experiments of 
mTF. Liposomes maximize the surface area for binding and minimize the presence of extra 
material in the rotor, such as membrane scaffold protein and trehalose. The percentages of mTF 
incorporation into liposomes of varying lipid compositions and detergents (deoxycholate and 
octylglucoside) are presented in Table 6.1 as analyzed by ELISA. Within error, the 100% PC 
was chosen for further study, as the 100% PC liposome preparation can be viewed as a “native” 
lipid environment for TF prior to vascular injury and exposure of PS to the outer leaflet.  
 
 
 
 
 
 109 
Table 6.1. mTF incorporation into liposomes of various compositions 
Preparation % Recovery Preparation % Recovery Preparation % Recovery 
8000:1 
(deoxycholate) 
100% POPC 
50 +/- 7 
8000:1 
(octylglucoside) 
100% POPC 
58 +/- 15 
8000:1 
(octylglucoside) 
80% PC/20% 
PS 
Out of range 
100:1 
(deoxycholate) 
100% POPC 
53 +/- 19 
100:1 
(octylglucoside) 
100% POPC 
49 +/- 10 
100:1 
(octylglucoside) 
80% PC/20% 
PS 
42 +/- 15 
75:1 
(deoxycholate) 
100% POPC 
46 +/- 9 
75:1 
(octylglucoside) 
100% POPC 
57 +/- 16 
75:1 
(octylglucoside) 
80% PC/20% 
PS 
46 +/- 8 
50:1 
(deoxycholate) 
100% POPC 
82 +/- 19 
50:1 
(octylglucoside) 
100% POPC 
48 +/- 8 
50:1 
(octylglucoside) 
80% PC/20% 
PS 
54 +/- 13 
30:1 
(deoxycholate) 
100% POPC 
65 +/- 8 
30:1 
(octylglucoside) 
100% POPC 
71 +/- 8 
30:1 
(octylglucoside) 
80% PC/20% 
PS 
68 +/- 7 
 
6.4.2. Solid-state NMR of reconstituted mTF 
CA T2 relaxation measurement studies were performed on 0.5 mg of uniformly labeled 
13C,15N mTF in 40% PS/60% PC Nanodiscs. As the sample temperature decreased from ~0 °C to 
-40 °C, the CA T2 relaxation times increased from 6.5 ms to 14.5 ms, respectively. With longer 
T2 relaxation times and by increasing the amount of material in the NMR rotor by switching to 
liposome preparations, multidimensional experiments become feasible for mTF. 13C 1D cross 
polarization and direct polarization experiments were performed on U-13C,15N mTF samples in 
both Nanodiscs and liposomes (Figure 6.4) above the phase transition temperature. The liposome 
preparation exhibits greater resolution and sensitivity in the aliphatic carbon region. In addition, 
strong POPC signals can be seen in both spectra at ~176 ppm and ~133 ppm.  
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Figure 6.4. 13C CP 1D spectra of mTF in lipid bilayers. (A) U-13C,15N sTF reconstituted into 80% 
PC/20%PS Nanodiscs. (B) U-13C,15N sTF reconstituted into 100% PC liposomes. Both spectra were 
acquired at 500 MHz (1H frequency) at 10 °C. 
 
6.4.3 Comparison of mTF & sTF 
 
Preliminary 2D 13C-13C correlation spectra of mTF have been acquired, and Figure 6.5 
shows a comparison of 13C-13C 2D spectra for mTF (blue) and sTF (red). Most of the resonances 
are conserved, indicating that the membrane-bound state retains its primarily β-sheet secondary 
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structure; however, several new resonances can be seen in helical conformations as is expected 
for mTF. Perturbations seen in the serine region (Figure 6.5), may be due to membrane 
interactions with residues Ser160-Ser163, which are thought to be involved in the TF/fVIIa 
putative exosite near the membrane surface;37 however, additional NMR experiments need to be 
performed to further examine the perturbation effects. It is notable that especially strong signals 
are observed for the spin systems corresponding to helical, hydrophobic residues (Val, Ile) in 
high abundance in the transmembrane helix (Figure 6.5), consistent with a robust interaction 
with the bilayer. Likewise, the helical conformation Ala signal pattern is stronger than the beta-
sheet conformation Ala signals, perhaps indicative of the favorable relaxation properties of the 
membrane-embedded residues of mTF. 
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Figure 6.5. Overlay of mTF and sTF 13C-13C 2D correlation spectra. Both spectra have 25 ms of 
DARR mixing with sTF (red) and mTF in 80% PC/20%PS Nanodiscs (blue) overlaid. 
 
 
6.5 Conclusions 
 
Here, investigations into the preparation of relipidated mTF and its associated solid-state 
NMR spectra were presented. Using a stepwise approach, perturbations to the sTF structure can 
be seen upon the addition of the transmembrane helix in mTF. The observation of additional 
helical residues in the solid-state 13C-13C 2D correlation spectrum reveals that NMR can be used 
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as a probe of TF structure and conformation. Additional NMR investigations with mTF in 
complex with fVIIa could be performed with a variety of ratios of PC and PS to identify how the 
lipid headgroups modulate the conformation of the TF/fVIIa complex. 3D NMR spectra were not 
collected on the existing mTF samples due to insufficient sensitivity; thus, relipidated mTF could 
not be site-specifically assigned. The use of 1.6 mm rotors would require less U-13C,15N mTF 
while still yielding high sensitivity NMR spectra; for difficult to produce proteins, such as mTF, 
1.6 mm rotors would make solid-state NMR studies feasible not only for mTF but for the 
TF/fVIIa complex as a whole.   
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CHAPTER 7  
Conclusions and Outlook 
 
7.1 Conclusions 
Solid-state NMR chemical shift assignments have been made for the majority of the 
backbone atoms in soluble tissue factor (sTF). The predicted secondary structure elements are 
comparable to the X-ray crystal structure data; however, several chemical shift assignments are 
missing in the loop and boundary regions of sTF. Preliminary spectra have been acquired on 
mTF inserted into Nanodiscs, and the structure of TF remains highly conserved from sTF to 
mTF. Examining perturbations of the chemical shifts will reveal residues that are involved in 
membrane-binding, as well as provide structural insights about the different conformations of TF 
in its various forms. The proposed experiments will aid in the ultimate goal of solving the 
structures of sTF and mTF in order to further understand the interactions between this vital blood 
coagulation protein and its associated phospholipid membranes.  
The work in this dissertation utilizes solution and solid-state NMR to elucidate structure 
and function of proteins involved in blood clotting. Additionally, significant improvements in the 
TF sample preparation are presented, enabling acquisition of high resolution and high sensitivity 
NMR spectra schematically outlined in Figure 7.1. Chemical shift assignment has been 
performed for 90% of the protein backbone of PEG-precipitated sTF and 85% for ammonium 
sulfate-precipitated sTF. Through a combination of solution NMR, solid-state NMR, and 
molecular dynamics, the backbone H-N and H-CA dynamics of sTF have been explored. 
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Progress made in mTF sample preparation and characterization will shed light on the structure of 
the TF/fVIIa complex as a whole.  
 
 
Figure 7.1. Characterizing the blood coagulation protein, TF: from sample to sructure. Overview of 
the characterization of proteins by NMR spectroscopy, showing sample preparation and biological 
significance, data acquisition, and structure elucidation.  
 
 
7.2 Outlook 
7.2.1 fVIII as an analog to fV 
Solution NMR chemical shift assignment for the fVIII C2 domain was described in 
Chapter 2, and similar approach could be applied to the fV C2 domain. fV forms part of the 
prothrombinase complex with fXa to activate prothrombin into thrombin.1 It also plays a role in 
the inactivation of fVIIIa.1 The C2 domains of clotting factors fV and fVIII are responsible for 
moderating membrane interactions and binding.2 Structurally, the two C2 domains are very 
similar, with a 45% sequence identity.3 Additionally, several mutations of the C2 domain in 
fVIII are conserved in fV.2 X-ray crystallography has been used to investigate the fV C2 domain 
at 1.9 Å resolution.4 Initial U-13C,15N labeled fV C2 domain has been purified. Solution NMR 
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experiments, including the 1H-15N HSQC, HNCA, HNCO, and HNCACB, could also be 
acquired on the fV C2 domain, for the purposes of chemical shift assignment and secondary 
structure prediction. A deeper understanding of the structures of the C2 domains of coagulation 
factors could potentially lead to the development of novel small molecule therapeutics designed 
to inhibit membrane binding or coagulation complex formation. In fact, work towards this end 
has begun with targeting fVIII,5 and if binding were understood at the atomic-scale using an 
integrated biophysical approach, small molecule drug design could be accelerated for 
coagulation complexes. 
7.2.2 Side chain dynamics of sTF 
Chapter 5 discussed dynamics for the backbone (N, C’, CA, and CB) atoms of sTF. In 
order to investigate the dynamics of TF further, NMR experiments targeting the side chain 
residues can be acquired. 1H-15N-13CX T-MREV6 solid-state NMR spectra have been acquired of 
sTF under the same conditions as the 1H-15N-13CA experiments described in Chapter 5. The 
gamma6 fitting algorithm6 can also be applied to the 13CX residues to elucidate side chain 
dynamics. It is expected that order parameters for the side chain residues will be lower (more 
dynamic) than those observed from the T-MREV experiments of the sTF backbone. Chevelkov 
et al. described that while backbone dynamics can be limited in range, side chain residues are 
likely to experience additional motions.7  
7.2.3 sTF/fVIIa complex studies 
Since the chemical shifts of sTF by itself have been well characterized (Chapters 3 & 4), 
the TF/fVIIa complex can now be studied more easily. TF could be prepared in complex with 
Gla-domainless fVIIa to simplify its NMR spectra. It was shown that the fVIIa Gla domain is not 
needed for the amidolytic activity of fVIIa bound to sTF or relipidated mTF to be retained.8 
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Solution NMR could be used to investigate the interactions in the ~75 kDa, sTF/fVIIa complex. 
Isotopic labeling schemes in combination with selective solution NMR experiments described by 
Kay and co-workers have been applied to biomolecular systems as large as 1 MDa.9 Methyl 
labeling (uniform [2H,15N] Ile δ1-[13CH3] Leu, Val-[13CH3/12CD3]) of highly deuterated samples, 
produced high quality methyl TROSY-HMQC spectra of the 82 kDa protein, malate synthase 
G.10 A uniformly labeled 2H,15N sTF sample could be prepared with the methyl groups of Ile, 
Leu, and Val labeled, and 2D methyl TROSY-HMQC spectra can be acquired on the sTF/fVIIa 
samples. Changes in the spectra can be easily monitored as fVIIa is titrated into the sTF sample, 
as functions of peak intensities and chemical shift perturbations. These experiments will provide 
high-resolution data for the large sTF/fVIIa complex and will facilitate the chemical shift 
assignment process. Solid-state NMR could also be used to investigate the TF/fVIIa complex for 
similar purposes; however, selective labeling would also need to be employed to avoid 
significant spectral degeneracy.  
7.2.4 mTF lipid correlation experiments 
 
While Nanodiscs provide a physiologically relevant state, the low amount of protein 
incorporated into the Nanodisc preparations remains a challenge for sensitivity in 3D solid-state 
NMR experiments. Reconstituting mTF into liposomes would potentially allow for a higher 
protein to lipid ratio and would facilitate multidimensional SSNMR experiments. Ladizhansky 
and co-workers have reconstituted the integral membrane protein, proteorhodopsin, into 
liposomes and successfully performed 3D heteronuclear correlation experiments for chemical 
shift assignment purposes.11 
Additionally, preliminary Cα T2 relaxation measurement studies were performed on 0.5 
mg of uniformly labeled 13C,15N mTF in 40% PS/60% PC Nanodiscs as mentioned in Chapter 6. 
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As the sample temperature decreased from ~0 °C to -40 °C, the Cα T2 relaxation times increased 
from 6.5 ms to 14.5 ms, respectively. With longer T2 relaxation times and by increasing the 
amount of material in the NMR rotor by switching to liposome preparations, 3D solid-state NMR 
experiments would become feasible. This is especially important when applied to lipid to protein 
correlation experiments performed above the lipid phase transition, where a 1H T2 filter can be 
used to select for the mobile 1H spins, while suppressing the rigid 1H signals.12 Here, 
magnetization transfer occurs in three steps using the lipid protons as the spin source. 
Magnetization is transferred from the methyl protons in lipid acyl chains, across the protein-lipid 
interface to the protein, and within the protein itself.12 To investigate site-specific interactions, 
SPC-5 mixing13 will be used in 13C-13C 2D correlation experiments. Spin-diffusion build-up 
curves, generated by varying the mixing times, will indicate which residues are embedded in the 
membrane, bound to the membrane, or are solvent-exposed.12 1H-13C 2D and 1H-13C-13C 3D 
spin-diffusion experiments have previously been performed on MSP embedded in Nanodiscs,14 
as well as on other systems in the Rienstra laboratory. When applied to TF, these experiments 
will provide qualitative information about which TF amino acids are in proximity to water or 
lipids. This information will be used in conjunction with the previous solid-state NMR chemical 
shift assignments to further understand the membrane-binding interactions of TF at the lipid 
interface.  
In all, the studies presented in this dissertation add insight into the structure and function 
of TF at the atomic-level, which is difficult to access via other biochemical techniques. The 
benchmark of chemical shift analysis that was described in Chapter 4 provides a framework for 
subsequent solid-state NMR studies of TF. Further investigations into the dynamics of sTF, in 
the form of side chain dynamics measurements, will provide additional insight into the atomistic 
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interactions of TF. With this NMR toolkit in hand, any perturbations to TF or the TF/fVIIa 
complex can be directly observable by NMR, providing a powerful approach to mechanistic 
elucidation in physiologically relevant states.  
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